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ABSTRACT 
JOKINEN, JEREMY D., Ph.D., December 2015, Psychology 
Determination of Change in Online Monitoring of Longitudinal Data:  An Evaluation of 
Methodologies 
Director of Dissertation: Bruce Carlson 
Longitudinal data collection is becoming increasingly common with the increased 
use of internet-based/technologically-based methods for data capture.  In fields as diverse 
as healthcare, engineering, fisheries management, political science, economics, and 
psychology, often analyses are conducted to determine if some change to the pattern of 
incoming data has occurred.  If a change has occurred analysis should make that 
determination as quickly as possible.  A data-pattern change is critical information, as it 
may indicate a change in the health status of patients, changing political attitudes, or, as 
in the case of the proposed study, changes to the safety profile of consumer products. 
The methods to analyze these longitudinal databases for indicators of change are 
as varied as the fields collecting the data.  To date, no single study has examined the 
varied methodologies to determine the relative accuracy of the methods and no study has 
attempted to determine the relative duration over which accurate change determinations 
are made.  This study examined the performance of these methodologies across three sets 
of simulated data as well as a single, large-scale safety database for a major consumer 
healthcare company.  The simulated data is comprised of random noise data streams and 
data streams with actual changes in data pattern (signals).  The three simulated data sets 
differ by the strength of the signal.  The consumer safety database is comprised of call 
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center data (n>725,000 records) from consumers who call to report a side effect (adverse 
event) while taking a company product.  Healthcare professionals flag products identified 
as having a confirmed safety signal.  Analyses were conducted retrospectively to 
determine if this change in safety status could have been detected by the statistical 
methods examined in this study for 30 days prior to the date of the confirmed signal.  For 
each of the three simulated data sets and the actual product safety database, mean and 
95% CI for sensitivity and specificity as well as AUC ROC over time line graphs were 
used to examine differences between statistical methodologies.   
Results of analysis the simulated data set and the actual data set indicated the 
modified control chart method performed well throughout the 31-day time period of 
analysis.  Modified control charting performed significantly better than other methods, 
proving to be a useful change detection method more than 20 days prior to the confirmed 
safety signal.  Though RCI, Bayesian, and CUSUM did not perform as well as modified 
control charting, they did perform significantly better than all other methods.  The 
computational simplicity of RCI makes this method worth considering for broad 
applications. 
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INTRODUCTION 
Time series data provide a wealth of information about the state of the subjects 
being observed.  Registered voter polling, national highway traffic accident records, and 
epidemiological data regarding the distribution of diseases provide insight to voter 
preferences, highway safety, and medicinal treatment effectiveness, respectively.  These 
data sets are collected by various entities and agencies and contain information necessary 
to enact all manner of policy changes in the public and private sector.   For example, 
CDC collection and dissemination of H1N1 flu data affect the distribution and 
administration of flu vaccines in the United States (“CDC - Seasonal Influenza (Flu) - 
Weekly Report,” n.d.).  National Highway Traffic Safety Administration (NHTSA) data 
regarding distracted driving led to the implementation of state laws prohibiting texting 
and cell phone usage while driving (“GHSA-2010_distraction.pdf,” n.d.).  Forecasting of 
fisheries catches are used to make changes to fisheries management policy (Stergiou, 
Christou, & Petrakis, 1997).   
 Examples of longitudinal data collection span a number of disciplines, including: 
public health, engineering, and the biological, political, and social sciences (Frisen, 
2011).  Additionally, these data represent an increasingly common situation brought 
about by technological advances and automation – online, continuous updating of 
longitudinal data (Moustakides, Polunchenko, & Tartakovsky, 2011).  The data may be 
counts, such as number of defects, or continuous data, such as the fill volume of fluid in a 
container, depending upon the application.  Each day, these longitudinal data sets are 
augmented with additional information about the events they purport to measure.  
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Though these data sets and disciplines attempt to address very different research 
questions, they are subject to similar data collection and analysis issues:  all utilize the 
collection of data over time, monitoring of the pattern of incoming data, and a method for 
determining when/if data have deviated from the historical pattern.  Should 
inconsistencies or changes be noted, an action is taken as a result of the pattern change, 
and monitoring is continued to determine if the change has had any effect on incoming 
data (Horváth, Husková, Kokoszka, & Steinebach, 2004; Liang & Zeger, 1986; Zeger & 
Liang, 1986).  Consider a patient that sees a physician regularly and routinely has a 
systolic blood pressure of 125 mmHg.  Taken as a single data point, a blood pressure of 
125 might be cause for additional tests or monitoring by the physician.  If the physician 
knows the patient has a history of a blood pressure of 125 without any other health 
problems, the physician will not be concerned.  However, if that patient’s blood pressure 
now reads 125 after routinely reading 110, that change in blood pressure would likely 
pique interest.   
 Before considering methods of analysis to determine if change has occurred, it is 
important to consider the type of data contained within the database.  Some data sets will 
include multiple observations of individuals recorded at different periods in time.  Such is 
the case with medical or psychological measurement of a particular patient with the aim 
of detecting a change in physiological or psychological status.  Alternatively, engineering 
or pharmacovigilance databases include measurements of many different individual units 
or people over time.  Because the measurements are made on different individuals, there 
isn’t necessarily a relationship or correlation between the values measured from one time 
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point to another.  Whether or not correlation exists, or to what degree correlation exists, 
will affect the choice of analysis methodology.  The present study focuses on the analysis 
of uncorrelated categorical (event count) data to determine if change in data pattern has 
occurred.  Additionally, the methodology of this study allows a retrospective 
determination of time to change detection by comparing the date of predicted change to 
the date the change actually occurred. 
In general, analyses designed to detect change in patterns of data have two results: 
A change is detected or a change is not detected.  Therefore the results of analyses to 
detect change in longitudinal data may be summarized in Table 1 below. 
 
Table 1.  2-by-2 Summary Table for the Determination of Change 
 True Change in Data 
Set 
 
No Change in Data 
Set 
 
Change Detected  True Positive False Positive 
No Change Detected False Negative True Negative 
Note: Sensitivity=(True Positive)/(True Positive + False Negative) 
Specificity=(True Negative)/(True Negative + False Positive) 
 
In the terminology frequently used in signal detection theory, some amount of change in 
historical data collection represents actual changes, or signals, in the pattern of data.  
Successful detection of these signals constitutes a correct detection, a true positive.  Other 
signals may be detected that are, in fact, the result of random fluctuations in data.  
Incorrectly labeling this random fluctuation as a signal constitutes an incorrect detection 
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– a false positive.  True positives and false positives have negative counterparts: no 
change detected when there is no change (true negatives) or the data analysis may suggest 
no change even if a change is actually present (false negative) (Szklo & Nieto, 1999).   
 The data in Table 1 above are often summarized using two common statistics to 
describe accuracy: sensitivity and specificity.  Sensitivity is defined as the proportion of 
actual positives which are identified by the test or analysis as being positive.  In Table 1 
above, this is equal to (True Positive)/(True Positive + False Negative).  Specificity is 
defined as the proportion of actual negatives that are identified by the test or analysis as 
negative.  In terms of Table 1 above, this is equal to (True Negative)/(True Negative + 
False Positive).  For a given test, the tendency of that test to declare “change” or “no 
change” may be adjusted from the extremes, all results indicate “change” or all results 
indicate “no change”, to various thresholds in between these extremes.  Each threshold 
results in combination of sensitivity and specificity pairs.  The combination of sensitivity 
and specificity pairs provides a summary of the operating characteristics, or accuracy, of 
a test or analysis under examination.  Several sensitivity and specificity pairs may be 
collected by adjusting the threshold.  These pairs can be combined on a coordinate plane 
to form an overall summary measure, the receiver operating characteristic (ROC) curve.   
 Over the past seven decades, numerous methods have been proposed to determine 
if change in a collection of data has occurred.  These methods fall broadly into two 
analysis categories:  static and online (Poor & Hadjiliadis, 2008).  Static refers to a fixed 
set of data.  Analyses of these data attempt to determine if and when a change in a data 
pattern has occurred in a defined, unchanging data set.  Online analyses examine whether 
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additional, newly collected data indicate a change relative to the data previously 
recorded.  Both static and online analyses share a goal of identification of statistically 
meaningful change in a pattern of data – has some behavior or trait substantially 
increased or decreased, for example.  Despite the numerous methodologies, little work 
has been done to quantify the accuracy of these measures (Kihara, Shimizu, Morikawa, & 
Hattori, 2011; Lehman et al., 2007; Matsushita et al., 2007).  For the present study, 
analyses will focus on the accuracy of change detection in online monitoring tasks.  
Specifically, does a statistical analysis that indicates a change in an online data pattern 
identify a true change or change that simply reflects chance variation? 
 The reasons for failing to quantify the accuracy of change methodologies are 
nearly as diverse as the methodologies themselves.  In engineering, any deviation from 
manufacturing specifications is unacceptable (Cheremisinoff, 1987).  There are usually 
narrow tolerances of permissible deviations within the specification, but any change 
outside of specification is not permitted.  A measured change is, in engineering, the end 
of the story.  There is no need to wonder if a change is due to chance variation because 
engineers must address every excursion from an expected data pattern.  Alternatively, 
consider the study of climatic events (Robbins, Lund, Gallagher, & Lu, 2011).  Robbins 
et al. examined historical tropical cyclone data in order to determine if the frequency 
and/or severity of cyclones has changed historically.  While their analysis suggests 
storms have increased in frequency and wind speed since 1995, the authors note their 
results conflict with other researchers who suggest no change occurred.  Due to the nature 
of data collection, it will take years to collect cyclone data that convincingly supports one 
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perspective or another.  Data on climate change are accumulated, pun intended, at a 
glacial pace.  Therefore, determining the accuracy of conclusions is complicated by slow 
data accumulation.  In the fields of psychological and physical healthcare, patient privacy 
may complicate follow-up to determine the true outcome (Hauben, 2007).  Additionally, 
for some types of diseases, determination of a true outcome is difficult to achieve 
medically (as with psychological illness or diseases that require autopsy to confirm) and 
therefore impossible to determine if change in status has occurred conclusively.  Finally, 
proprietary databases, such as those possessed by insurance, pharmaceutical, or other 
medical companies, contain key pieces of corporate intellectual property (Lehman et al., 
2007). The contents of these databases are not routinely made known to the public. Given 
the numerous challenges, it is not surprising that methods of determining change have 
proliferated without an accompanying critical examination of the accuracy of these 
methods (Lehman et al., 2007). 
 The present study will address two key unmet needs in the literature.  First, 
change detection methodologies from diverse disciplines of study will be compared 
simultaneously in an online signal detection task.  This analysis will facilitate a direct 
comparison of the operating characteristics of these methods in order to inform choices 
for future study and change detection practice.  Second, this comparison will be 
conducted using both simulated data and data collected within an actual consumer 
product safety database.  Therefore, the results of this study will extend previous 
comparisons based upon simulated data to include diverse methodologies utilizing actual 
online data. 
  19 
   
The online data set is a 4-year longitudinal safety database comprised of more 
than 725,000 data records.  In order to be included in the study, each consumer product in 
the database must have 4 years of continuous data to facilitate the analyses.  Each data 
record contains information regarding a consumer product, a reported adverse event, and 
a date of occurrence of the adverse event, at a minimum.  The consumer products are 
personal care products typically purchased at grocery and drug stores across the US and 
Canada.  Adverse events are varied physical reactions ranging from mild headaches or 
rashes to potentially life threatening allergic reactions.  Additional information about the 
person reporting the adverse event and person who experienced the adverse event (if 
different) may also be available.  Each data record is examined, in context with other data 
records for a particular product, to determine if a safety signal is present for a given 
product-adverse event pair.  Examples of product-adverse event pairs include: sunscreen 
product associated with severe sunburn, pain reliever associated with liver toxicity, and 
allergy medication associated with dry mouth.  A safety signal is the outcome of interest 
for this study and the outcome which will attempt to be identified by the change detection 
methodologies. 
The procedure for determination of a safety signal by organizations regulated by 
the FDA (or EMA in Europe) is the result of a rigorous, labor intensive process 
conducted by trained safety personnel.  Identifying incoming data as indicating a safety 
signal, defined as the change in the frequency or intensity of adverse events over time 
(Powell, Ryan, & Pattishall, 2010), involves examining the current product-adverse event 
report (e.g., Product001 made a consumer nauseous, reported today) in context of the 
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historical reports of this combination of product-adverse event (e.g., Product001 made 
other consumers nauseous in the past).  The goal is to determine if a change in the 
reporting pattern is perceived.  There may be many occurrences of ‘Nausea’ in the 
database, but at some point in the time series, if the evaluation by medical review 
determines that the frequency with which that event has been reported for Product001 has 
changed then the event at that time period is flagged as indicating a safety signal.  Signals 
are reviewed by supervisory medical safety officers, physicians specially trained in the 
use and indications for a class of products, for confirmation.  If there is a disagreement 
between the initial review and supervisory review, a third medical safety officer will 
provide input and a final determination is made between the three reviewers.  In the 
language of diagnostic testing, this final determination of safety signal is the gold-
standard outcome. 
The use of this expert-based determination of an outcome is not without 
reasonable criticism.  Regardless of the rigor applied to the review, undoubtedly, the 
human element introduces variability to the determination of a safety signal.  An 
alternative might be to use records of randomly generated data with a known number of 
numerical changes introduced.  While increasing experimental control, this methodology 
departs from the naturalistic observation desired in this study.  Authors have noted that 
evaluation of change detection techniques are often conducted using artificial/simulated 
data sets, but for the reasons discussed above, there is little information regarding the use 
of these techniques to predict outcomes in an actual judgment task (Matsushita et al., 
2007).  Additionally, human judgments or imperfect measurements are often used to 
  21 
   
make gold standard determinations in healthcare (sometimes called “alloyed gold 
standard”).  This study is designed to address the need for real-world measurement of the 
performance of these analyses in a judgment task in addition to comparing those results 
to a more typical simulated data task designed to mimic the real-world data collection 
(Spiegelman, Schneeweiss, & McDermott, 1997).   
Of the approximately 725,756 reports in the raw call center database, there are 
22,150 unique product-adverse event combinations with a minimum of 4 years of data.  
Four years of data are needed as some analyses to be examined require a run-in period of 
2 years of data.  The latter 2 years of the data will be used to test the performance of all 
analyses under evaluation.  Of these 22,150 unique product-adverse event combinations, 
2,892 product adverse event pairs included signal during the run-in period and were 
therefore omitted from the primary analysis, leaving 19,258 product adverse event pairs.  
Of the 19,258 pairs, the proportion flagged as safety signals versus the proportion flagged 
as no safety signal will facilitate comparison of change methodologies using a 
combination of sensitivity, specificity, and time-to-signal detection simultaneously, 
thereby assessing not only accuracy but also the time to detection simultaneously.  In this 
analysis, those data records flagged as ‘safety signals’ (n=2,952, 15.3%) represent the 
target or signal distribution and those flagged as ‘not safety signals’ (n=16,306, 84.7%) 
are the components of the noise or foil distribution.  This data set of signal and noise 
components allows the statistical methods of change detection to be compared on the 
basis of their ability to detect signals both quickly and accurately.  Results of these 
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analyses will suggest an optimal method that maximizes sensitivity and specificity and 
minimizes time-to-detection. 
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ATTEMPTS TO IDENTIFY CHANGE 
Various statistical methodologies have been proposed to address the issue of 
change within static and online longitudinal data sets (Horváth et al., 2004).  The 
methodologies are as disparate as the fields that have attempted to address the issue.  
Researchers in the fields of psychology, statistics, economics, engineering, and public 
health have published methodologies assessing change in longitudinal data (Fotopoulos, 
Jandhyala, & Tan, 2009).  Regardless of field of study and methodology employed, the 
ultimate goal is rapid and accurate determination of a deviation from the historical pattern 
of data (Unnikrishnan, Veeravalli, & Meyn, 2011). 
Control Charting 
 Within the field of engineering, various methods of control charting, and 
accessory analyses, have been developed to insure product quality using longitudinally 
collected data (Dovich, 1992).  Control charts date to the early 1920s and were proposed 
as a methodology for identifying and rectifying quality issues (Ipek, Ankara, & Ozdag, 
1999).  As products are completed on a manufacturing line, a sample of units is selected 
and significant characteristics measured.  For example, at the end of a Coca-Cola 
manufacturing run, a sample of 12-ounce cans of product might be selected.  The amount 
of cola in each can may be measured to insure the filling process is accurate.  Too much 
cola will result in cost overruns and under filling could result in legal action based on 
mislabeling a 12-ounce can that does not contain 12 ounces of product.  Data points 
representing the actual amount of cola in each can may be plotted against an average 
volume (presumably 12 ounces) to examine differences from this expected mean.  
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Though control charting is originally an engineering analysis, it is now accepted more 
broadly as a technique of quality control, applicable to a variety of settings, including 
environmental pollution monitoring, epidemiology, surgical error monitoring, and 
radiological quality control (Corbett & Pan, 2002; Corcoran & Speekenbrink, 2007; 
Woodall, 2006). 
In the most basic sense, a control chart is simply a plot of a statistic over time 
(Fallah & Akhavan, 2010).  The plot includes a center line, a target, and upper and lower 
control limits determined by the data collected.  In the example above, a control chart 
based upon sample means would typically use µ, the population mean of 12 ounces, for a 
center line and upper control limit (UCL) of µ+3*σ and lower control limit (LCL) of µ-
3*σ.  Mu and sigma are usually estimated from the available data prior to charting.  Three 
is typically chosen as the multiplier for the upper and lower control limits to ensure the 
‘in control’ region includes 99.7% of the observations and excursions represent 
deviations from the process that are extremely unlikely (<1%) due to chance (Champ, 
Woodall, & Mohsen, 1991).   
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Then, samples are drawn and the sample means plotted against the mean and 
upper/lower control limits.  In terms of hypothesis testing, the null hypothesis 𝐻0: 𝑋𝑡 =
𝜇, the value computed at time t is compared to the mean, is tested against the alternative 
𝐻1: 𝑋𝑡 ≠ 𝜇.  Figure 1 displays a typical control chart using hypothetical data for the 12-
ounce can manufacturing example (Note: 12-ounces cans are capable of holding slightly 
more than 12 ounces of fluid to account for variability in fill volume). 
 
 
Figure 1. Typical Control Chart for Statistical Process Control 
 
In the example above, the 23rd lot has an observed mean volume in excess of the 
UCL and corrective action was completed prior to lot 24, the data above indicate the 
correction was successful.  In addition to µ and σ, control charts have been developed 
that utilize median and range, p, the probability of a product defect, and binomial 
variance, and counts of defects based upon a Poisson distribution (Stoumbos, Reynolds, 
& Woodall, 2003).   
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 The simplicity of control charting allows the methodology to be applied in a 
variety of settings.  Within the heath care field alone, the examples are quite diverse.  The 
Joint Commission on Accreditation of Healthcare Organizations (JCAHO) adopts control 
charting for quality evaluations of member institutions seeking accreditation (Lee & 
McGreevey, 2002).  Treatment of patients suffering from depression by primary care 
physicians may be improved through control charting of treatment and patient progress 
(Spettell et al., 2003).  Control charting is a method of tracking patient outcomes in 
patients suffering from asthma (Boggs, Wheeler, Washburne, & Hayati, 1998), patients 
treated by interventional cardiologists (Matheny, Ohno-Machado, & Resnic, 2008), and 
cardiac patients treated out-of-hospital (Chen, Chung, Hu, Fan, & Yang, 2011).  Across 
fields other than health care, control charting shares similar popularity and widespread 
application (Corbett & Pan, 2002; Fallah & Akhavan, 2010; Ipek et al., 1999; Margavio, 
Conerly, Woodall, & Drake, 1995) 
 Though ubiquitous and exceedingly useful, control charting for longitudinal data 
is subject to certain limitations (King, 1995).  The selection of the data to establish 
measures of central tendency and variability about that measure, identification of samples 
– presumably random samples – to be drawn, and the tendency for the traditional 3*σ 
control limit to be insensitive to changes in the process that are not sufficiently extreme 
have impacted the usefulness of control charting (Aparisi & de Luna, 2009).  
Additionally, as can be seen in Figure 1, the control limits are parallel lines surrounding 
the target value, µ.  Therefore, situations where the data collected include an underlying 
trend, increasing or decreasing, are not analyzable using traditional control charts.  The 
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underlying trend would eventually breach the control limits and indicate a change in the 
data pattern – even though the pattern didn’t change at all, the trend in the data caused the 
excursion beyond the control limit.  As a result of these limitations, numerous variations 
to the original methodology have been proposed.    
CUSUM Chart 
Cumulative Sum (CUSUM) control charts are proposed as a method for 
combating the insensitivity of the traditional control chart and, in some respects, to move 
away from the dogmatic use of 3*σ criteria for control limits in traditional control charts 
(Cheremisinoff, 1987; Page, 1961). The creation of a CUSUM chart begins in the same 
manner as creating a control chart, an initial target value is specified, generically noted as 
k, though k may take values of central tendency, such as µ. Then, for each data point, the 
deviation from k is computed and the deviation for each data point is added to the 
deviations for each subsequent sample.  So, for r samples, the cumulative sum, 𝑆𝑟, is: 
𝑆𝑟 = �Xi − k𝑟
𝑖=1
 
where Xi is the value for data point i and k is a target value, such as a historical mean or 
engineering specification. A graphic representation of these deviations from the target 
may be plotted, as in Figure 1 for the standard control chart, resulting in a CUSUM 
control chart.  The result is a data table or graph which, if the process is under control, 
should remain near the value 0.   
Page’s original work focused on the one-sided analysis, the event that occurs if 
the quality of a process under observation is decreasing (Page, 1954).  Page recognized 
that the opposite situation is important, quality improvements should be noted, but for 
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simplicity he focused on unidirectional analyses.  In this unidirectional analysis, 0 serves 
as a lower bound and the value of 𝑆𝑟 and the value at any time point, r, is equal to: 
 𝑆𝑟=max(0, 𝑆𝑟−1+(Xr − k)) 
The collection of data stops if 𝑆𝑟>h, where h is a predefined critical value determined to 
indicate that a change has occurred in the series of data points.   
 Page left the framework for CUSUM analyses flexible, which allows for use of 
various critical values and data distributions.  Three important notions are contained in 
Page’s formulation:  First, the most recent data point is used to update previous 
information – making the analysis well suited for dynamic longitudinal data.  Second, a 
target value is defined independent of the collection of data.  The exact specification of 
target value is left to the analyst, but specification requires the analyst to clearly delineate 
an expectancy for the data collection.  Finally, a critical value for stopping data collection 
is specified.  As with the target value, the critical value may be determined to suit the 
needs of the analysis in order to trade-off sensitivity or specificity as appropriate. 
Often, the work of Page is extended to more complicated analyses (Woodall, 
2006).  For example, a frequent formulation of CUSUM analysis is to determine if 
change occurs in Poisson distributed count data (Shu, Jiang, & Tsui, 2011).   
𝑆0=0 
 𝑆𝑟=max(0, 𝑆𝑟−1+𝐿𝑟) 
is the basic form of the of the CUSUM chart from time 0 to time r. 𝐿𝑟 is the score 
statistic.  In the case of the Poisson formulation, the score statistic is the log of the ratio of 
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a null distribution of event counts, 𝑓0(𝑋𝑟) and alternate distribution of event counts, 
𝑓1(𝑋𝑟).  Taking the log of the ratio gives the log-likelihood ratio 
 𝐿𝑟 = 𝑙𝑙𝑙 �𝑓1(𝑋𝑟)𝑓0(𝑋𝑟)� 
 𝐿𝑟 represents the increment, the increase or decrease of 𝑆𝑟, based on the rth observation 
of the CUSUM chart.  The alternate and null distribution functions may be chosen 
according to the data included in the analysis.  For Poisson distributed counts, the 
probability mass functions for a given population size, 𝑛𝑟, and event count, 𝑋𝑟, are 
conditionally independent and may be represented 
 𝑓0(𝑋𝑟|𝑛𝑟) = 𝑒𝑒𝑒(−𝑛𝑟𝜋𝑜)(−𝑛𝑟𝜋𝑜)𝑋𝑟𝑋𝑟!   and 
 𝑓1(𝑋𝑟|𝑛𝑟) = 𝑒𝑒𝑒(−𝑛𝑟𝜋1)(−𝑛𝑟𝜋1)𝑋𝑟𝑋𝑟!  
for the null probability, 𝜋𝑜, and alternative probability, 𝜋1.  If data are accumulated that 
support the alternate hypothesis over the null hypothesis, the 𝐿𝑟 value is greater than 1, 
resulting in increasing 𝑆𝑟 values.   As with all CUSUM analyses, the data accumulation 
continues until 𝑆𝑟>h, with h being a cutoff selected based upon criteria to identify a 
change in data pattern as quickly as possible without excessive false alarms. 
Control charts, CUSUM or traditional, suffer from certain limitations. First, there 
is a requisite specification of an expectancy (target).  Second, once established, the 
expectancy does not update.  So, if one is monitoring a system where expected values 
might change over time, the CUSUM chart is not well suited, at least not without altering 
the formulation to include a process for updating the target value.  Third, traditional 
CUSUM charts weight observations equally, though some authors have argued that most 
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recent observations should carry more weight in the calculation than the earlier 
observations (Nezhad & Niaki, 2010; Shu et al., 2011). 
Several additional methodologies have been proposed to fine-tune the sensitivity 
of control charting, traditional or CUSUM, to more quickly identify changes in a system 
and address the limitations noted above.  Western Electric rules and Nelson rules add 
additional criteria for determining if a process is out of control (Stoumbos et al., 2003).  
For example, 4 consecutive data points above or below a mean constitute a potential 
signal of a process out of control according to Western Electric rules for control charts.  
In addition to a single data point more extreme than 3* σ, a signal may be declared if 9 
consecutive data points lie on the same side of µ, if  2 consecutive points lie outside of 2* 
σ, of if 4 out of 5 points lie beyond 1* σ (Cheremisinoff, 1987).  The hope is that 
inclusion of additional criteria will identify a potential out-of-control process sooner 
without resulting in a large number of false-positive alarms (Margavio et al., 1995).   
Alterations to CUSUM methodologies have been proposed to augment the 
analysis or overcome purported shortcomings. For example, use of Bayesian posterior 
distributions might prove more sensitive to changes in data patterns (Unnikrishnan, 
Veeravalli, & Meyn, 2011; Yang, Dumont, & Ansermino, 2006).  In longitudinal data 
collection situations where data are very limited and the specification of a target “k” 
value is difficult, certain methods have been proposed that allow for updating of the k 
value while data collection is ongoing (Hutwagner, Thompson, Seeman, & Treadwell, 
2005; Shu, 2011).  These attempts to tailor the methodology continue to champion use of 
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the analysis while simultaneously elucidating the shortcomings of the original 
methodology. 
Sequential Probability Ratio Tests 
Sequential probability ratio tests (SPRT) evolved as another method for 
examining change in longitudinally collected data (Grigg, Farewell, & Spiegelhalter, 
2003a; Kihara et al., 2011; Mukhopadhyay, Datta, & Chattopadhyay, 2004; 
Mukhopadhyay & de Silva, 2008). Dating back to the 1940’s, the methodologies remain 
relevant to analyses conducted in disciplines such as computer science, agricultural 
science, education, and finance, to name a few.  Similar to the Poisson CUSUM chart 
discussed above, the sequential probability ratio test is a framework for sequential 
analyses of one hypothesis, a null hypothesis, against an alternative.  The hypotheses are 
compared simultaneously by computing a summation of the ratio of likelihoods, or log 
likelihoods, for a series of data points.  At time point i, the sequential sum, Si, is equal to 
 𝑆𝑖 = 𝑆𝑖−1 + 𝑙𝑙𝑙 ⋀𝑖  
where Λ𝑖represents the ratio of likelihood functions for the null and alternate hypotheses.  
Stopping boundaries for the summed log likelihoods are established to stop data 
collection if data suggest one hypothesis is supported over the other to a sufficient 
degree.  The cutoffs, prior to log transformation, are typically represented as a and b 
having the following properties 
0<a<1<b<∞ 
where “a” represents a cutoff that results in a decision that data support the null 
hypothesis and “b” represents a cutoff that results in a decision that data support the 
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alternative hypothesis.   If one considers variables that are exponentially distributed, the 
likelihood may be denoted by the following function 
𝑓𝜃(𝑥) = 𝜃−1𝑒𝑥𝑒(−𝑥/𝜃) 
where x is a random variable and θ is a scale parameter describing the dispersion of the 
distribution.  Researchers may hypothesize that dispersion takes different forms under 
null and alternate hypotheses.  Often these alternative dispersion assumptions represent 
dispersion that might be observed if the data pattern were to change.  The log likelihood 
of the ratio of null and alternate hypotheses for exponentially distributed data is stated 
𝑙𝑙𝑙� (𝑥) = 𝑙𝑙𝑙 �𝜃1−1𝑒𝑥𝑒(−𝑥/𝜃1)
𝜃0
−1𝑒𝑥𝑒(−𝑥/𝜃0)�𝑖  
which is computed for values, x, relative to the null and alternative hypothesis 
parameters, 𝜃0and 𝜃1, respectively.  Sequential x values are inputted to the equation 
above, and each resulting log likelihood value is summed with all preceding log 
likelihood values.  In the event the x value is more likely according to the alternate 
hypothesis than the null hypothesis, the numerator above increases in value relative to the 
denominator.  In the event the summated value exceeds the upper bound, b, evidence 
supports the alternate hypothesis over the null hypothesis and a change in the data pattern 
is detected.   
 The parallels between sequential probability ratio tests and CUSUM are obvious.  
In fact, both methodologies were developed at roughly the same time period, between 
1950-1960.  CUSUM methods as originally formulated by Page do not explicitly employ 
likelihood ratios, though a simple extension of the original formulation makes this so 
(Shu et al., 2011).  The main difference between the methodologies is evident in terms of 
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the summation.  CUSUM charts always have a lower bound of 0 and a single cutoff value 
h>0, whereas sequential probability ratio tests have a lower and upper bound stopping 
point, a and b, for evaluation of the evidence in favor of the null or alternate hypotheses.   
Sequential probability ratio tests are subject to limitations. There are 
circumstances when the information available is not sufficient to compute sequential 
probability ratios.  For example, in consumer drug safety, it is impossible to know exactly 
how many individuals at a given time are exposed to a drug.  Additionally, hypothesis 
tests rely on assumptions, such as conditional independence of the observed counts and 
consistency of the null and alternate hypothesis throughout the data accumulation period, 
which may or may not be justified (Chen et al., 2011). Violations of these assumptions 
may severely hamper the ability to accurately and reliably determine type I and type II 
error probabilities (Mukhopadhyay et al., 2004). 
Also paralleling the development of CUSUM methodologies, numerous 
modifications have been proposed to augment the method and address potential short-
comings.  Extensions to the sequential probability ratio test have been developed to 
examine multiple hypotheses simultaneously (Horváth, Kokoszka, & Steinebach, 2007; 
Lai, 2004) to allow for changes in the expectations that make the prespecified hypotheses 
adaptable over time (Kihara et al., 2011; Li & Kulldorff, 2010) and to maximize test 
sensitivity under varying conditions (Walker & Kulldorff, 2010). 
Continued evolution of the methodology has led to widespread use of sequential 
probability ratio tests in a number of disciplines.  Popular applications include 
determination of insurance fraud and credit fraud (Bate & Reynolds, 2010), clinical trial 
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adaptive designs (Sebille & Bellissant, 2000), improvements of medical outcomes in 
healthcare systems (Grigg, Farewell, & Spiegelhalter, 2003b; Nkeng et al., 2011), and 
early stopping in computerized educational testing (Aue & Horváth, 2004).  The 
application of these sequential probability and CUSUM methods are, perhaps, only 
limited by the number of out-of-the-box software algorithms currently available.  Rightly 
or wrongly, simplicity is an important consideration in the broad adoption of statistical 
algorithms to detect change in longitudinal data (Lehman et al., 2007). 
Chi-Square and Modified Chi-Square Tests 
 Chi-square tests and comparisons of simple proportions have emerged as a 
methodology for change detection.  The methodology is simple, comparing the 
proportion of total events that are target events at one time point versus another. This 
methodology has been used to measure changes in opinion research (Naylor, Reisch, & 
Valentine, 2010), prostate cancer diagnosis (Zhu, Roehl, Antenor, & Catalona, 2004), 
return of memory function following surgery (Gunstad et al., 2010), and pain, depression, 
and the propensity to return to work after accidents (Corbière, Sullivan, Stanish, & 
Adams, 2007). The ease with which the methodology is applied makes the analysis 
appealing to many disciplines, but the simple pre-post time point comparison may limit 
the informativeness of the analysis. That is, additional longitudinal data are ignored in 
favor of the most recent time points or time trend data is agglomerated over large time 
periods, masking any trend information.  Additionally, the chi-square test may not be 
appropriate under conditions where observed counts are small or overly sensitive when 
sample sizes are large (Almenoff et al., 2007). Specifics regarding the computation of the 
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chi-square statistic in a longitudinal data analysis problem are discussed below in the 
context of modifications to the chi-square test. 
In healthcare fields, several modifications to chi-square analyses have been 
proposed to address concerns regarding the methodology.  Specifically, the comparison 
between 2 time points may be overly sensitive to change due to the large sample size 
involved in analyses.  In order to make the method less sensitive, additional criteria were 
applied to the chi-square test of significance (Banks et al., 2005). In 2001, Evans, Waller, 
and Davis recommended the inclusion of a requirement that the target events occur more 
than 3 times (n>3) in each time point, that the ratio of the target events to total events in 
the second time point be twice the ratio at the first time point (Proportional Reporting 
Ratio [PRR]>2) and the chi-square value (1df) is 4 (𝜒2>4) (Evans, Waller, & Davis, 
2001). Table 2 below illustrates a typical longitudinal analysis problem and computation 
of the components of Evan’s criteria. 
Table 2. 2x2 Longitudinal Data for 𝜒2 Analysis 
Time Point 0 Time Point 1 Total 
Target Event a b a+b 
All Other Events c d c+d 
Total at each Time a+c b+d 
Applying Evan’s criteria to the above example, in Table 2, if 
a. both a and b >3
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b. PRR=(b/b+d) / (a/a+c)>2, and 
c.  𝜒2=[(ad-cb)2(a+b+c+d)] / [(a+b)(c+d)(b+d)(a+c)] >4 
then there is a significant change from Time Point 0 to Time Point 1.  This methodology 
has been increasingly employed in analyses of databases for consumer products, 
pharmaceuticals, and vaccines ( Almenoff et al., 2005; Egberts, 2007; Li, Xia, Deng, & 
Jiang, 2008; Pariente et al., 2009; Vellozzi et al., 2009; Zeinoun, Seifert, & Verstraeten, 
2009) 
Though simple, the method of computing and comparing proportions to detect 
change has proven to be nearly as effective as methods far more computationally 
complex (Almenoff et al., 2005; Deshpande, Gogolak, & Weiss-Smith, 2010; Hauben, 
Madigan, Gerrits, Walsh, & Van Puijenbroek, 2005).  Hauben et al. analyzed data from a 
large-scale public database for pharmaceutical safety.  Results indicated that 
methodology based upon Evan’s criteria performed nearly as well as Bayesian 
methodologies that required substantially greater computing power and statistical 
expertise.  However, no analysis to-date has examined the sensitivity and specificity of 
these methods relative to the amount of time prior to the confirmation of the signal.   
Change Point Regression 
Regression-based methodologies have been developed to identify change in a 
system utilizing prospective data collection.  In the area of analysis known as change 
point regression, Aue and Horvath (2004), Chen et al. (2010), and Chu et al.(1996), 
among others, derive methods for assessing change based upon deviations in the 
regression parameters (Aue & Horváth, 2004; Chen, Tian, & Ding, 2010; Chu, 
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Stinchcombe, & White, 1996).  In each case, analytical methods are derived that 
determine if a change in a regression parameter has occurred in an accumulation of data.  
Consider a simple linear model 
 Yt = β0 + β1*Xt +et    
where the Y observations are modeled as a function of the intercept, β0 , and the product 
of the slope and X observations, β1*Xt .  Criteria are established, such as the method of 
least squares, which specifies the conditions for modeling the parameters, i.e., model 
parameters β0 and β1 such that the squared error (difference) between the predicted Y and 
observed Y values is minimized.   
In change point regression, the proposition being tested is that a linear model 
describes a portion of the data and a different linear model describes the data after the 
change point.  This analysis can be described by the addition of another parameter to the 
simple linear regression model to account for this change point   
 Yt = β0 + β1*(Xt –cp) for x<cp    
 Yt = β0 + β2*(Xt –cp) for x≥cp    
where cp is a point of change along the X-axis.   In the event the cp parameter 
significantly increases model fit, the cp parameter estimate is examined to determine the 
location of the change point along the X-axis.  In the event cp=o, there is no change point 
in the longitudinal data collection along the X-axis, β1 = β2 and the equations above 
simplify to a single equation.   
 Numerous authors have examined the validity of change point regression in an 
online data monitoring task. Riffenburgh and Cummins proposed a simple linear 
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regression methodology (Riffenburgh & Cummins, 2006).  This methodology relies on a 
moving average computation of the F statistic to determine if a significant change has 
occurred in a series of data.  Höhle and Paul describe Poisson-based regression 
procedures for determination of change in a series of count data (Höhle & Paul, 2008).  
Liang and Zeger proposed an extension of generalized linear models applicable to 
longitudinal data analysis which detect discontinuities in a time series as statistically 
significant changes to regression parameters prior to and post change (Liang & Zeger, 
1986).  Though statistically diverse, regression methods for determining if a statistically 
significant change has occurred share a general framework. 
Each regression method incorporates common elements:  A null hypothesis of no 
change in the regression parameter or mean, a training set of data upon which the null 
model is based, a collection of additional data, and a test for statistically significant 
deviations from the null state.  Zeileis et al. and Chen and Tian compared the various 
methods for detection of change in prospectively gathered data (Chen & Tian, 2010; 
Zeileis, Kleiber, Krämer, & Hornik, 2003).   Chen and Tian examined different lengths of 
training data sets and different amounts of information after a change point.  Both factors 
influenced the ability of the methodologies to detect change in the regression parameters, 
less data in each case making the detection of change more difficult.  Since a primary 
goal of online monitoring of data is the identification of change as soon as possible, these 
limitations are critically important.   
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Bayesian Methodologies 
 Bayesian methodologies have been developed to efficiently screen longitudinal 
data for the presence of changes in data patterns.  Though Bayes’ theorem has existed for 
hundreds of years, the analysis of data using Bayesian methods is relatively recent, 
depending upon the emergence of simulation methods and readily available computer 
power (Berry, 1995).  The most frequent use of Bayesian methods in an online 
monitoring task is the computation of the empirical Bayesian geometric means and 
posterior distribution probabilities (EB01 and EB05) in the screening of marketing and 
drug safety data (DuMouchel, 1999).  The computation proposed by DuMouchel 
compares a ratio of observed to expected data distributions.  Both observed and expected 
data are modeled using Bayesian methodologies, relating the data acquired to a posterior 
distribution through a likelihood function based upon a presumed (prior) distribution of 
the data (Berry & Stangl, 1996; Carlin & Louis, 2008).  Because this is an empirical 
Bayes process the prior distribution is derived from the accumulated data (Kruschke, 
2010) 
Modeling proceeds in terms of Bayes theorem: 
 𝑃(𝐴|𝐵) = 𝑃(𝐵|𝐴)𝑃(𝐴)/𝑃(𝐵) 
which can be rewritten: 
𝑃(𝐴|𝐵) = 𝑃(𝐴) x 𝑃(𝐵|𝐴)
𝑃(𝐵)  
which is the conditional probability of A given the data (B) = (prior distribution of 
A)*(Likelihood function – the conditional density of the data given the parameters).  In 
terms of a healthcare analysis, this would be akin to a probability of a headache in your 
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database (P(A)) times the probability of Product001 being the drug of interest given a 
headache is reported (𝑃(𝐵|𝐴)) divided by the probability a report being associated with 
Product001(P(B)).  In DuMouchel’s computation, the event of interest is modeled (say, a 
particular adverse event associated with a particular drug) based upon the data.  The 
posterior conditional density may be generated, which is the observed distribution.  All 
other drugs in the database may be modeled to generate a conditional distribution of this 
particular adverse event for all other drugs, which is the expected distribution.  The ratio 
of these distributions reveals the extent to which the specific drug-adverse event 
combination differs from the distribution that is expected based upon all other data in the 
database. If these distributions overlap, then the observed and expected distributions do 
not differ and the geometric mean of the difference between these distributions is near 1.  
If the observed quantity is greater than the expected quantity, the geometric mean 
difference between the distributions is greater than 1.  Because the difference between 
observed and expected is represented by a distribution of values rather than a single 
value, the 95% credible intervals may be computed.  If the lower bound of the 95% 
credible interval (often called EB05) exceeds 1, the observed value is significantly 
greater than the expected value (Aniagolu, 2009).  This methodology has proven 
particularly useful when the underlying distribution of the events of interest is unusual, 
such as distributions which are highly skewed or contain a large proportion of 0 
responses (zero-inflated distributions) and, therefore, would not likely meet the 
assumptions required for other statistical methodologies (Efron, Storey, & Tibshirani, 
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2001).  This is the case when modeling counts of events over time when those events 
occur infrequently, like credit card fraud or serious adverse health outcomes. 
Reliable Change Index (RCI) 
 The field of psychology has attempted to address the issue of change in 
longitudinally collected data in response to questions regarding the effectiveness of 
psychotherapy and psychometric instruments (Kazdin, 1993; Ogles, Lunnen, & 
Bonesteel, 2001).  The primary question of interest is whether a patient observed over the 
course of therapy has exhibited a change in behavior.  Similar to the examples presented 
in other fields discussed above, psychotherapists observe patients repeatedly and collect 
quantitative (e.g., the Beck Depression Inventory) and qualitative information over time.  
At various points throughout therapy, the therapist must ask the question “Has this patient 
improved?”  The therapist must investigate the accumulated data and determine if 
meaningful change is apparent.  As with previous examples, there is anticipated 
measurement error so data points will fluctuate due to chance.  The answer to the 
question about a change in patient behavior over time has two components: statistical and 
clinical.  In addition to determining if a statistically meaningful change has occurred, the 
change must be meaningful to the patient (Moleiro & Beutler, 2009).  Though it may be 
possible to detect some statistically significant change in the longitudinal data, it may be 
unclear if that change represents true improvement (or decline) in the patient’s mental 
status. 
 The issue of statistical change within the context of an experiment is simple 
enough.  The pre- and post-experimental measures may be collected, differences and 
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associated variability calculated, and an appropriate statistical test conducted. However, 
the issue is more complicated when considering whether one patient, one score, or one 
observation is somehow statistically different from historical data.  This is the issue 
addressed by the work of Jacobson and Truax (Jacobson & Truax, 1991).  In examining 
the issue of statistical significance, Jacobson and Truax proposed the notion of reliable 
change – change which is unlikely to be due to chance.  They proposed a measure of 
reliable change, the Reliable Change Index (RCI): 
 RCI = 
𝑋𝑝𝑜𝑝𝑝 − 𝑋𝑝𝑟𝑝
𝑆𝑑𝑑𝑑𝑑
  
 where Xpost is the score on some psychometric instrument following treatment, Xpre is the 
score on the same instrument pre-treatment, and Sdiff is the standard error of the 
instrument.  Note that for the present study, Sdiff is computed from the run-in data and not 
a characteristic of an instrument. An RCI value greater than 1.96 is viewed as evidence of 
a reliable change.  Subsequent to the publication of the RCI, numerous authors have 
examined the use of this analysis (Ankuta & Abeles, 1993; Lunnen & Ogles, 1998; Speer 
& Greenbaum, 1995).  The overall conclusion is that RCI is a valid indicator of change 
that is likely not due to chance.  Though RCI indicates statistical change, the clinical 
meaningfulness of that change requires further analysis. 
Changes established through the use of RCI require further examination to 
determine if the change has medical/clinical meaningfulness.  A behavior change should 
be observable and identifiable to the patient, healthcare provider, friends/family, or some 
combination of these.  No single definition of clinical change is apparent, though there is 
general agreement that statistical change and clinically meaningful change are different 
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concepts (Jacobson, Follette, & Revenstorf, 1984).  Determining clinical meaningfulness 
has often involved comparison to normative samples (Kendall, Marrs-Garcia, Nath, & 
Sheldrick, 1999).  That is, the behavior of treated individuals should resemble in some 
critical manner the behavior of normative (untreated) others. Therefore, true clinical 
change is indicated by statistically verified, reliable change and clinical criteria 
established to identify the observed change as meaningful relative to normative 
comparison. Thus, the combination of statistical, such as through the use of RCI, and 
clinical change, such as through normative comparison, form the components of 
determining clinically significant change. 
Clinical significance studies relying on the RCI have dominated this literature.  
As of the publication of their review, Ogles et al. noted that 74 articles examining clinical 
significance utilized the RCI (Ogles, Lunnen, & Bonesteel, 2001).  However, of the 74 
articles, only 26 (35%) correctly incorporated both the notion of reliable change and a 
defined clinical significance cutoff.  In other words, most articles included the statistical 
but not the clinical component of the clinical change.  The authors cited difficulty 
identifying a clinical cutoff as the primary reason for failure to include this component.  
Nonetheless, RCI continues to maintain popularity with researchers, with applications in 
the study of depressive disorders (Moleiro & Beutler, 2009), postnatal depression 
(Matthey, 2004), and general psychological and physical functioning (Newnham, 
Harwood, & Page, 2007) to name a few.   
Interestingly, the field of epidemiology has followed a path of research that 
parallels the clinical significance field of study in psychology.  Throughout the 90’s and 
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early 2000’s, epidemiologists set to the task of determining the clinical significance and 
minimally important difference (MID) when using quality of life instruments (Cella, 
Bullinger, Scott, & Barofsky, 2002; Sprangers, Moinpour, Moynihan, Patrick, & Revicki, 
2002).  MID has been defined as the “smallest difference in score in the domain of 
interest that patients perceive as important, either beneficial or harmful, and which would 
lead the clinician to consider a change in the patient’s management.”  (Guyatt, Osoba, 
Wu, Wyrwich, & Norman, 2002).  Stated differently, the MID is the smallest score on an 
instrument which is associated with an identifiable clinically significant change. Not 
surprisingly, the development of measures of MID closely parallels the discussion of 
determination of clinical significance in the psychology literature. 
Historically, the determination of MID change employs one of two general 
methodologies: distribution-based or anchor-based methods (Eton et al., 2004).  
Distribution-based methods involve parsing the variability of the instrument being 
employed, typically ½ the standard deviation for the instrument (Revicki, Hays, Cella, & 
Sloan, 2008). So, any change from pretest to posttest scoring that exceeds the value of ½ 
the standard deviation for the instrument would be considered a MID. Anchor-based 
methodology involve association of scores on an instrument to other observable 
characteristics, such as changes in patient behavior, functioning, or satisfaction. 
Additionally, some authors have attempted to identify the MID using both distribution-
based methodology and anchor-based methodology (Eton et al., 2004).   
 Throughout the early 2000’s MIDs have been computed for several instruments 
in various clinical settings.  For example, research related to determination of headache 
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impact, melanoma, breast cancer, and prostate cancer has recently been published 
(Askew et al., 2009; Coeytaux, Kaufman, Chao, Mann, & DeVellis, 2006; Eton et al., 
2004). This proliferation was partly fueled by the increased need to demonstrate clinical 
benefit of therapy to the insurers/payors involved in the health system (Askew et al., 
2009).   Recognizing the importance of this avenue of research, the US FDA issued 
guidelines for the determination of MID (Kemmler et al., 2010). 
As with the development of measures of clinical significance in psychology, 
epidemiologists Kemmler et al. (2010) summarized approaches to MID, limitations, and 
proposed further development.  Notably, they propose that both statistical and clinical 
considerations must be combined in order to determine MID. Additionally, the 
commonly used statistical criterion, ½ the standard deviation, sets the bar for MID too 
low, resulting in false positives.  Kemmler and his colleagues recommend the use of the 
Jacobson and Truax RCI to determine the distribution-based component of MID.  This 
component is combined with anchor-based methods to result in a MID that is both 
clinically meaningful and statistically reliable. 
Assessing Accuracy 
An important consideration to distinguish among the change detection methods is 
the ability of the methods to accurately identify change.  Accuracy may be assessed in a 
number of ways, but a simple 2x2 framework provides a flexible, reliable method to 
compare accuracy across methodologies.  In a psychological healthcare example, patients 
may be administered a test to determine if suicidal tendencies are present.  Then, the 
individuals are followed prospectively to determine if suicide is attempted or not.  At the 
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conclusion of the follow-up period, responses to the test are compared to the observed 
outcome.  Results are tabulated as follows in Table 3. 
 
Table 3.  2-by-2 Summary Table for the Computation of Sensitivity and Specificity 
 Suicide Attempted Suicide not attempted 
Test Positive A B 
Test Negative C D 
 
The response values from the suicidal tendency test are dichotomized to yield “test 
positive” and “test negative” categories.  The dichotomized test results are tabulated 
against follow-up of each patient to determine if suicide was attempted or not.  The 2x2 
tabulation is used to compute summary statistics related to the performance of the test. 
 Sensitivity and specificity may be computed for the above table.  Sensitivity, the 
proportion of events for which the test is positive given the subject attempted suicide, is 
equal to A/(A+C).  Specificity, the proportion of events for which the test is negative 
given the subject has not attempted suicide is computed D/(D+B).  These measures may 
be considered simultaneously to describe complementary, negatively correlated, desirable 
characteristics of the test.  If the threshold for “test positive” is decreased so that more 
tests are declared positive, values for cell A and cell B will increase relative to quantities 
in cells C and D.  The result is an increase in sensitivity, A/(A+C) nears 1 as A is large 
relative to C, with a corresponding decrease in specificity, D/(D+B) nears 0 as B is large 
relative to D. 
 Given that analysis methods may provide results on a continuous scale, a series of 
cutoffs may be selected for each method, generating a series of 2-by-2 tables like that in 
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Table 3.  Then, pairs of sensitivity and specificity values may be computed for the 2-by-2 
table generated.  The resulting sensitivity and specificity values may be plotted on 
coordinates to generate a receiver operating characteristic (ROC) curve.  For the ROC, 
sensitivity is plotted against 1-specificity to provide monotonically non-decreasing curves 
such as the example in Figure 2 below.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.  Sample ROC Curve 
 
The ROC provides an overall summary of methodology performance.  The major 
diagonal indicates chance performance.  In other words, a method with a measured 
performance along the major diagonal is indicative of a method that is no more 
informative than guessing.  To the extent that the ROC is above the diagonal, the blue 
shaded area in Figure 2, the methodology is more informative to the user.  As more of the 
area in Figure 2 lies below the plotted curve, the more informative the methodology is 
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and the more that methodology can be relied upon to correctly identify signals without 
incorrectly identifying non-signals as signals.  At the most extreme case, an ROC curve 
which completely encompasses the area of the graph is a test that correctly identifies all 
signals and non-signals. 
 The signal detection concepts of sensitivity and specificity have been applied in a 
variety of fields of study to examine statistical methodology accuracy (Algarabel & 
Pitarque, 2007; Corcoran & Speekenbrink, 2007; Qian et al., 2010; Rossi, Lampugnani, 
& Marchi, 1999; Zheng & Heagerty, 2004). The concept may be extended to the question 
of change determination in an online monitoring task given a definitive determination 
that change has occurred – a gold standard in diagnostic testing terms - is available.   
 Each change detection methodology may be applied to a data set which contains 
gold-standard positives and negatives.  For each method, the threshold is increased and 
decreased, sensitivity and specificity computed, and ROCs plotted.  The analysis yielding 
the ROC that encompasses the greatest area, a measure ranging from 0 to 1.0 represented 
by the combined blue and green shaded sections of Figure 2, is considered the most 
discriminating methodology. 
 Consider an example of a pharmaceutical safety surveillance system for over-the-
counter drugs.  In the typical safety system, patients or physicians are invited to report to 
the manufacturer any complaints regarding a product whether or not the complaint results 
in untoward health effects, i.e., an adverse event.  This is a so called “passive” 
surveillance system (Powell, Ryan, & Pattishall, 2010).  The manufacturer relies not on 
active solicitation of a patient’s health status, but rather adverse events are reported at the 
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volition of the consumer or physician.  For the majority of months, fortunately, there are 
few reported adverse drug effects.  The number of events is generally monitored month 
after month, with minor upward and downward inflections in the number of reports.  
Overall, the pattern of reports is consistent around some mean number of adverse events 
with some degree of variance about that mean.  Occasionally, due to legitimate health 
concerns, product recall, distribution of manufacturing issues, or simply publicity, the 
number of reported adverse drug events will increase.  The ability of the safety 
surveillance system to accurately detect deviations from normal that are indicative of 
patient safety issues has substantial public health ramifications.  For example, timely, 
well informed action may prevent additional harmful medicines from being distributed to 
the public.   
 Within a safety surveillance system, sensitivity and specificity of an analysis of a 
change in data pattern may be computed.  Analyses may be applied as the data are 
collected, and results dichotomized to “change detected” or “no change detected” as in 
Table 4 below. 
 
Table 4.  2-by-2 Summary Table for the Determination of Change in a Safety System 
 Confirmed Safety 
Issue 
No  Safety Issue 
Change Detected A B 
No Change Detected C D 
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Medical review of the safety data is conducted to determine if a safety issue is 
truly present in the reported data.  Medical review is the gold-standard, but the 
examination of individual data points by medically trained personnel is time consuming 
and expensive.  So, a data analysis method with desirable sensitivity and specificity is 
valuable to pharmaceutical manufacturers.  Sensitivity, A/(A+C), and specificity, 
D/(D+B), may be computed. Similarly, any assessment of change in longitudinal data 
may be assessed using sensitivity and specificity statistics.   
Throughout these investigations in various fields, no single solution has emerged 
as a change-detection best-practice.  Certain fields prefer simple quantitative criteria and 
analyses, such as control charting in engineering, whereas psychology and epidemiology 
gravitate toward a statistical and clinical combination of criteria, and all fields continue to 
investigate more computationally intensive methods, such as Bayesian methods, as these 
techniques become more mainstream.  Absent a single solution, the present study 
proposes several qualities that are desirable for the identification of change in 
longitudinal data. These desirable qualities will serve as a basis for comparison and 
evaluation of analysis methodologies.  Subsequently, the methodologies described above 
will be compared using a novel ROC methodology by plotting sensitivity, specificity, and 
time to detection on a single line graph.  
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DESIRABLE QUALITIES OF LONGITUDINAL DATA ANALYSES 
 Though no analysis is definitively superior to others for determination of change 
in longitudinal data collection, certain qualities can be identified that distinguish amongst 
the alternatives.  The computation should be simple; the analysis should detect both 
changes from- and returns to- the baseline state; and the analysis should leverage 
available historical data.  Finally, the analysis should maximize sensitivity and specificity 
while reducing the time taken to detect a signal.  
Computational Simplicity 
 With increasing memory capacity available in present-day computers and servers, 
the amount of data available to researchers is increasing rapidly.  The volume of data is 
limiting the ability of traditional statistical software on desktop computers to analyze the 
data.  Therefore, as noted by Joseph Verducci and others at the Nonparametric Statistics 
and Statistical Learning Conference (2010), this places statistical analysts in much the 
same position that analysts found themselves throughout the 1970s (Deshpande, Gogolak, 
& Weiss-Smith, 2010).  Computational algorithms must remain simple or other data 
manipulation trickery, such as cherry picking of certain cases and random sampling of 
data from large data sets, is required to make analysis possible.  So, a successful 
algorithm for detection of changes in behavior is necessarily simple in order to 
accommodate computational limitations imposed by the massive data sets to which they 
may be applied. 
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Return to Baseline 
 Detection of deviation from a baseline state is the primary goal of any of the 
change detection methodologies.  A secondary benefit of interest to certain fields, such as 
engineering, healthcare, and economics, is an indication that a measured change has 
passed and a longitudinal system has returned to a baseline state (Woodall, 2006).  In 
these fields, a change is indicative of, hopefully, a temporary state that will return either 
with or without some intervention.  If intervention is required, one would like to know 
when that intervention may be terminated.  In a simple statistical example, the baseline 
state may be comprised of a measure of central tendency and a measure of variability.  
These pieces of information provide the reviewer of an analysis an indication of “typical” 
responses as data are accumulated.  The measure of variability provides insight into the 
amount of deviation one might reasonably expect about the measure of central tendency.  
If the traditional variability is exceeded – a change as data are collected – one could 
continue to collect data until there is a return to the pre-change levels. 
Determination of Change that Utilizes Historical Data 
 It seems intuitive that, if a large amount of historical data is available from a data 
set and those data indicate a stable pattern of results, then even slight changes in that 
pattern may be of interest.  If a baseball pitcher throws a fastball between 91 and 93 mph 
for 20 games, a decline to 89 mph in game 21 might be indicative of a health concern or 
training issue.  However, if that same pitcher throws between 91 and 93 mph for 3 games, 
a fastball of 89 mph at game 4 might go unnoticed.  Similarly, a desirable quality for a 
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statistical algorithm is that long histories of stable data carry more weight than shorter 
histories of stable data.  
 Conversely, the statistical algorithm should not be overly sensitive when there is 
little historical data, assuming false alarms are to be minimized.  If so, the statistical 
algorithm will alert very frequently when little data are available.  Consequently, this 
may create a boy-who-cried-wolf situation, causing decision makers to doubt any 
occurrences where a signal may be indicated. 
Sensitivity and Specificity of Results 
 The ability to trade-off sensitivity and specificity for the situations deemed 
necessary is beneficial for a methodology to be applied across disparate fields of study.  
Using a healthcare database example, if one hopes to identify changes consistent with a 
patient at risk for severe depression, specificity may be sacrificed in order to insure 
sensitivity.  That is, one may be willing to risk frequently alerting physicians to the 
possibility of severe depression if this minimizes the possibility of missing a patient at 
risk for severe depression (and the associated consequences).  Alternatively, one may be 
willing to sacrifice sensitivity in certain instances as well.  Consider a human resource 
system intended to identify changes in travel and expense reporting indicative of fraud.  
The cost of false positives – accusing employees of fraud leading to alienation and 
possible wrongful termination – is high.  One would like an analysis system that would 
appropriately trade off specificity, resulting in increased false negatives, in order to insure 
the few positive results are true positives.   Therefore, an analysis system that is 
adjustable depending upon the decision maker’s willingness to accept certain errors 
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relative to others is desirable to have a more universally acceptable approach.  In a 
comparison of several methodologies, as in this current study, sensitivity and specificity 
should be relatively high across a range of potential thresholds. 
Time to Detection 
 Setting accuracy aside for a moment, time taken to detect a signal is critically 
important in online monitoring of longitudinally collected data (Almenoff, LaCroix, 
Yuen, Fram, & DuMouchel, 2006; Brown et al., 2009).  Analyses which detect change 
only after a tremendous amount of evidence for the change is gathered will be 
meaningless in most fields.  One wouldn’t bother collecting data online, usually at great 
expense, if time was not of the essence.  Surveillance of online data is often defined in 
terms of time.  Surveillance is an analysis “…to detect an important change as soon as 
possible” (Frisen, 2011, p. 612). 
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CANDIDATE METHODOLOGIES FOR ASSESSING CHANGE 
Methodologies will be compared which fulfill two basic criteria.  First, the 
methodologies must allow assessment of deviations from a baseline state in an online 
process.  Second, the methodologies must be able to determine, in as short a period of 
data collection as possible, if data are outside of what might normally be expected.  The 
following methodologies will be compared using longitudinal data sets:  Chi-square test, 
modified chi-square (Evan’s criteria), control charting and modified control charting 
(Western Electric Rules), CUSUM charts, empirical Bayesian methods, Reliable Change 
Index, and change point regression. Sequential probability ratio tests, discussed above, 
are not included in this study due to the computational similarity to CUSUM charts, 
particularly in the case of Poisson distributed variables that will be analyzed in the 
present study.  
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METHODS 
 This naturalistic observation study is based upon data from a consumer care 
center database at a large pharmaceutical, medical device, and consumer products 
corporation based in the U.S.  Utilizing this data set as opposed to a simulated set of data 
directly addresses noted shortcomings in previous attempts to examine analyses of 
change in online data.  Notably, that the data set and the resulting analyses might be 
applicable to randomly generated data with statistically imputed ‘alerts’ but not to a 
naturally occurring online monitoring task.  In order to insure comparability to previous 
research as well as provide a basis for testing the methodologies when signal strength is 
weaker and stronger than anticipated, the analyses will be run on 3 simulated data sets in 
addition to the naturalistic observation data.  
Data Sets Employed 
There were four data sets employed in the analyses for this study, three simulated 
data sets and one naturalistic observation data set from a large consumer call center 
database.  The rationale for selecting three simulated data sets is to determine the 
consistency of results for small, medium, and large effect size pattern changes in the 
simulated data, then examine the consistency between the simulated data and the actual 
consumer call center data.  The simulated data sets are created to provide a comparison to 
the live data set and provide context for the analysis results.  A study whose purpose is 
simulation would examine many more simulated data sets; however, this simulation is 
intended only to augment the live data analysis results. 
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Simulated Data Sets 
In order to facilitate comparison of the performance of the change determination 
methods, simulated data sets were constructed which mimic the characteristics of the 
actual data set employed in the primary analysis of the proposed study.  The SAS random 
data generator function was used to create Poisson-distributed data.  The Poisson 
distributed data represent the calls received at the Customer Care Center (CCC) daily for 
each product-adverse event pair.  In order to maintain comparability to the primary 
analysis, 19,258 product-adverse event pairs were simulated, 2,506 of which included the 
presence of a signal in the final 30 days of the longitudinal data.  Analyses confirmed no 
signal was present during the time period prior to the final 30 days.  Details of the noise 
and signal data are given below. 
• Noise Distribution: Four years of daily product-adverse event counts were 
generated using a Poisson random number generator function for the (19,258 
– 2,506) n=16,752 noise product-adverse event pairs.  The final noise data set 
includes (365*3 + 366) n=1,461 random daily data points for each of the 
16,752 product-adverse event pairs with mean=1.0. 
• Signal Distribution:  The data set for the signal distribution for the 2,506 
signal product-adverse event pairs was generated in exactly the same manner 
as the noise distribution until day 1,430.  The final 31 days of data include 
imputed signal generated from a Poisson regression data simulation created in 
SAS (Wicklin, R., 2013, pp. 225-230): 
eta=Beta*X 
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Pred(Y)=rand(Poisson, eta) 
where Beta is the regression parameter varied, as noted below, to represent 
different signal strengths.  X is a uniform random variable, eta is the outcome 
of the linear combination of Beta and X, and the response variable, Pred(Y), is 
a Poisson distributed outcome variable with mean and variance equal to 
parameter=eta. 
Three data sets were created of 19,258 total product-adverse event pairs each with 1,461 
daily data points.  The three simulated data sets differed by the strength of signal that 
resulted from increasing the value of the regression parameter in the Poisson regression 
equation used to generate the signal distribution.  The weak signal simulated data set 
employed a 0.5 regression parameter, moderate signal simulated data set employed a 1.0 
regression parameter, and the strong signal data set employed a 2.0 regression parameter.  
Pilot testing of these regression parameters indicated that the distribution of the predicted 
Y values were upwardly shifted from the noise distribution, but the resulting counts were 
consistent within daily call volume observed in the actual data set. 
Naturally Observed (Actual) Data 
The naturally observed, actual data to be employed in this study were from a 
consumer call center for a major international consumer product, pharmaceutical, and 
medical device manufacturer.  The data were acquired as the author of this research is an 
employee of the company.  The process for identifying data for analysis was described 
in-text as well as graphically (Figure 3, Data Processing) below.  All calls to this call 
center were logged into a database by call center personnel.  Each call recorded in the 
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database, and therefore each row of the database, included at a minimum three key pieces 
of information: a specific consumer reporting an event for a specific product name and a 
single adverse event.  In the event the consumer reported more than one adverse event, 
the primary adverse event was identified in the database as the rank 1 adverse event.  All 
adverse events reported by consumers were processed through a medical dictionary to 
insure terminology and spelling were consistent across the database.  In the current 
database, there are 725,756 reports from consumers for 3,280 unique consumer products 
(e.g., pain relieving medication X, 100mg tablets) which include 4,140 unique adverse 
event terms (e.g., headache, abdominal pain upper).  Data were examined in product-
adverse event pairs (i.e., ‘Are there a greater number of reports of headache (adverse 
event) for Pain Reliever A (product) than would be expected’).  This process for data 
handling is conducted as a matter of procedure by safety physicians.  From the raw 
database, there were 78,344 unique product-adverse event pairs of data selected for 
transformation and analysis by the author. 
From this database, data were selected for inclusion in the analysis.  To be 
included, a product must have four years of history in the database. Four years is 
necessary to insure sufficient data for certain analyses, which require 2 years of run-in 
data and 2 years for analysis.  The reports must contain complete information for the 
variables for the product name, the adverse event experienced, and the determination by 
the safety team that a safety signal is present or not.  Because the determination by the 
safety team is time consuming (5-60 days to complete), it is necessary to have a data 
cutoff at least 60 days prior to analysis.   Therefore, June 1, 2013 was selected as the 
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cutoff, so products included must have been available on the market continuously 
between June 1, 2009 and June 1, 2013.  The result was a database of 1,777 unique 
products that contains 22,150 unique product-adverse event pairs.  
In order to insure unusual data collected during the run-in period did not 
adversely affect the threshold values, it was necessary to exclude any product-adverse 
event pairs that contained signals in the run-in period.  Signals in the run-in period would 
inflate variance estimates and impact the sensitivity and specificity of analyses.  An 
analysis was conducted to identify signals in product-adverse event pairs in the run-in 
period to exclude these data streams prior to analysis.  The results indicated of the 22,150 
unique product-adverse event pairs, 2,892 included signals in the run-in period. Therefore 
19,258 product-adverse event pairs were available for analysis. 
Each product-adverse event pair was forwarded to the safety team for medical 
review.  The primary medical reviewer considered the content of each call, the reported 
adverse event, the product involved, and the historical context of the product-adverse 
event combination.  The primary medical reviewer indicated if the event represents a 
safety signal or an expected outcome.  Following the initial review, a secondary review 
was conducted to confirm or disconfirm the initial review.  If there was a discrepancy, a 
third medical reviewer decided the final status within the database – signal or no alert.  
Therefore, the database contains all product-adverse event combinations as well as results 
of expert medical review of these reports.  A safety signal was declared only if the 
reported event was unusual or serious (hospitalization or death) or when the amount of 
evidence of a potential signal had accumulated over a period of time suggesting that the 
  61 
   
product had an unexpected effect upon the consumer.  Fortunately, the former case was 
rare, but the latter case required time for evidence to accumulate.  As discussed below in 
Secondary Analyses, analyses were conducted on the different types of safety signal 
determinations.  The primary analysis was conducted on the safety signals resulting from 
a quantitative accumulation of evidence.  Of the 2,952 safety signals, 2,506 were 
quantitative safety signals and the remaining 446 were signals declared as a result of 
qualities of the consumer report (e.g., a medically serious event or an event that is 
medically unusual relative to this or similar products). The process for identifying 
product-adverse event pairs of data for analysis is summarized in Figure 3, Data 
Processing. 
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Figure 3. Data Processing 
 
Data Handling and Identification of Gold Standard Signal 
Data were acquired from spontaneous consumer reports and triaged according to 
the data flow in Appendix B: Data Flow.  Each call to the customer care center was 
entered into a database.  The information contains, at a minimum, the product involved, 
the event or reason for call, identification of the person calling, and the date of the event.  
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If the data included a potential adverse event, either related or unrelated to a company 
product, the data record was forwarded to a second database for medical safety review.  
Medical review was conducted by safety scientists and pharmacovigilance physicians 
trained in the administration and use of specific company products.  Only consumer 
records pertaining to the scientist’s/physician’s area of expertise were directed to their 
attention.  Each medical review, which included evaluation of the time course of a 
particular series of adverse events, concluded with a determination to escalate the issue 
for management review or not.  This decision to escalate the issue occurred when a safety 
signal had been validated by the review process and further action was warranted (up to 
and including complete product recall).  The date of the escalation for medical review 
was captured in the database.  The decision to escalate the issue was considered evidence 
that a safety signal was present, the gold standard for the change analysis.  In the current 
database, roughly 20 percent of all product-adverse event combinations were escalated to 
management review.  See Appendix C:  Sample from the Adverse Event Database for a 
listing of typical records captured in the database.  
An issue which complicates the determination of the gold standard is the varying 
factors that may lead to a determination that a safety issue exists.  Essentially, three 
factors lead to a determination of a safety issue:  
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1. A change in the pattern of typical adverse event reporting 
2. A single, serious or atypical case that is sufficiently extraordinary to be 
determined a safety signal for medical reasons 
3. A safety signal that might result from comparing one product to the adverse 
event reports of another, similar product 
Quantitative determinations of change were directly applicable to #1 above only, 
though all three resulted in determinations of safety signals.  The result was a gold 
standard of the assessments of change that could be variable as a result of the different 
factors leading to determinations of safety issues.  As a result of required regulatory 
documentation, the reason for determination of a safety signal was recorded in the safety 
signal database.  Therefore, the primary analysis was conducted using the gold standard 
of safety signals escalated as a result of a change in the pattern of adverse event reporting 
(factor #1).  The processing of the data and the counts of product-adverse event 
combinations available for analyses are described above in Figure 3. 
 The final data set for analysis was constructed by taking all data available in the 
safety database and creating a new variable for the gold standard safety signal 
determination and a variable for the factor that led to the determination of the safety 
signal (Factor 1, 2, or 3 above).  The newly computed variables facilitated the 
determination of the time component of the analysis.  Each time component variable as 
titled ‘Signal_<Product>_<AE>_XX’ where <Product> is the specific product involved, 
<AE> is the adverse event reported, and XX is a 2 digit number to distinguish among 
repeated <Product> <AE> combinations.  Each time component variable was assigned a 
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value of 0 on the day of a confirmed signal, -1 on the day prior to a signal, -2 two days 
prior, -30 for the day 30 days prior, etc. for all days prior to Day 0.  The process for 
handling the signal and the non-signal data for computing Day 0 to Day -30, the time 
period utilized for comparison of methodologies, is represented graphically in the 
example below. 
 
 
Figure 4. Time Trends of Headache AE Counts of 4 Different Products 
 
In Figure 4 above, the 4 trend lines represent the daily counts of adverse events of 
‘Headache’ for 4 hypothetical products.  Over the course of time, 2 safety signals were 
identified, noted by the red circles.  The remaining 2 products were determined to have 
no safety signals related to the adverse event ‘Headache.’  Since these determinations of 
safety signal may occur at any point, the safety signals needed to be matched at a time 
point (Day 0) as noted in Figure 5 below. 
 
  66 
   
 
Figure 5. Time Trends of Headache AE Counts of 4 Different Products – Day 0 
 
As the figure above represents, the 2 products with safety signals were matched so 
that the safety signals occurred on the same day, Day 0.  No changes were made to the 
data for products without safety signals.  For no safety signal data, Day 0 was June 1, 
2013, the final date of data extraction.  From Day 0, the data points for Days -1 to -30 
were identified for both the signal and non-signal products, as in Figure 6 below. 
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Figure 6. Time Trends of Headache AE Counts of 4 Different Products, Day -1 to  
Day -30 
 
With Days -30 to Day 0 identified, the analyses were conducted at each day 
utilizing the products-adverse events identified as signals or non-signals.  The selection 
of 30 days as the time frame for computation of the analysis was based upon pilot data 
analyses conducted on a similar safety database. Results indicated that differences 
between methods emerged between 2 and 4 weeks prior to the confirmed signal date. 
 In order to maintain confidentiality regarding the products under review, all 
product names in the database were masked.  Rather than trade or generic names, each 
product was represented as Product001, Product002, Product003, etc.  Each product falls 
into a hierarchy, e.g., pain relief medicine X, 100mg, and pain relief medicine X, 
pediatric liquid, fall into the pain relief X product category.  If the data summarization 
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required product grouping be presented, those groupings were masked if it were possible 
to determine the specific product involved.    
Occasionally, personally identifiable information regarding the caller was 
recorded in the database.  In order to comply with the Health Insurance Privacy and 
Portability Act (HIPAA) of 1996, no reporter demographic or locality information was 
used in the present study (“Health Information Privacy,” n.d.). 
Comparison of the Candidate Methodologies 
 The desirable characteristics for the candidate methodologies are summarized in 
Table 5 below. 
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Table 5. Summary of Candidate Methodologies by Desirable Characteristics in Online 
Monitoring 
Methodology Simple1 Change2 Baseline3 AUC ROC 
Sens/Spec4 
Time5 
Chi-Square Yes Yes Some Unk Unk 
Modified Chi-square 
(Evan’s Criteria) 
Yes Yes No Unk Unk 
Control Charting Yes Yes Yes Unk Unk 
Modified Control Charting 
(Western Electric Rules) 
Yes Yes Yes Unk Unk 
CUSUM Chart No Yes Yes Unk Fast 
Bayesian No Yes Some Unk Unk 
RCI Yes Yes Yes Unk Unk 
Change Point Regression Yes Yes Yes Unk Unk 
1Methodology is computationally simple 
2Methodology detects change in online monitoring of data 
3Methodology leverages historical baseline data 
4Operating characteristics (sensitivity or specificity) of method 
5Time to detect a change in the online data collection task  
 
Most notably in Table 5, the data regarding sensitivity and specificity of these 
methodologies is sparse. No study compares the methods head-to-head in an analysis of a 
single database that would allow direct comparison of the sensitivity, specificity and 
time-to-detection.  An optimal algorithm for analysis of longitudinal data would meet all 
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of the characteristics noted above and have acceptable values for sensitivity, specificity, 
and time.    
Statistical Analyses 
In order to examine the basic characteristics of the data employed in the study, 
descriptive statistics summarizing the analysis data set were generated.  Continuous 
variables were summarized using mean, standard deviation, n, and range.  Categorical 
variables were summarized with n and percent. 
Primary Analysis 
The primary analysis for this study is the computation of the mean and 95% CI 
for the AUC ROC for each of the change detection methodologies for Days -30 to Day 0.  
The statistical methodologies are listed in Table 6, Change Detection Methods Summary.  
For each analysis method listed, there is a different statistical cutoff for determination of 
an alert.  The alert cutoff is the criterion for determining if the methodology indicates 
signal present or signal absent. Then, the analysis result for a particular product-adverse 
event pair is compared to the gold standard safety signal determination. 
The alert cutoff presented in Table 6 is the alert cutoff typically employed in 
change detection analysis.  The alternate cutoffs were chosen to facilitate additional 
computations of specificity and sensitivity.  Alternate alert cutoffs were selected that 
were more and less conservative than the cutoff typically employed in all cases except for 
modified chi-square.  Modified chi-square methodology is noted for being a very specific 
measure of change detection.  Therefore, only less conservative cutoffs were employed 
for this methodology.  
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Table 6. Change Detection Methods Summary 
Methodology Alert  
Cutoff 
Alternate  
Cutoffs 
Chi-Square  Χ2(1 df) p<0.05 p<0.2, p<0.1, 
p<0.025  
Modified Chi-square (Evan’s Criteria) Χ2(1 df) p<0.05, 
and 
N>3 events, and 
PRR>2 
p<0.2, p<0.1 and 
p<0.025 
(Other requirements 
unchanged) 
Control Charting N>mean+3*sd N>mean+2.5*sd 
N>mean+2.0*sd 
N>mean+1.5*sd 
Modified Control Charting (Western 
Electric Rules) 
 
 
N>mean+3*sd 
 
 
N>mean+2.5*sd 
N>mean+2.0*sd 
N>mean+1.5*sd 
(Other requirements 
unchanged) 
CUSUM Chart S>3 S>1, S>2, S>4 
Bayesian (EB05) EB05 >1.0 EB05>1.5, 
EB05>0.8, 
EB05>0.5 
RCI RCI>1.96 RCI>2.3 RCI>1.68 
RCI>1.54 
Change Point Regression Significant 
change parameter 
(p<0.05) within 
Day -30 to Day 0 
p<0.2, p<0.1, 
p<0.025 
 
Computational Details for Each Methodology 
Table 6 summarizes the methodologies employed and the cutoffs for 
determination of test positive/test negative results.  For a given methodology, analyses 
were computed for Day -30 to Day 0, 31 total analyses, for each of the 4 cutoff values, 
across the entire database of 19,258 unique product-adverse events pairs. The result was 
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8 methods x 4 cutoffs x 31 time points = 992 2x2 tables for computation of 
sensitivity/specificity values.  This sequence of analyses was computed for the primary 
analysis.  The secondary analyses of subsets of data were conducted in similar manner, 
resulting in the 992 2x2 tables for each data subset as described below in Secondary 
Analyses.  
Chi-square 
The chi-square test of independence of proportions may be used to determine if 
the proportion of product-adverse event counts is different under varying conditions or 
treatments.  In the case of longitudinal data collection in this study, the proportion of a 
specific product-adverse event in the most recent 30 days (i.e., for the analysis at Study 
Day -30, the most recent 30 days previous to Day -30, Day -30 to Day -59) was 
compared to the proportion computed from the data 30 days prior (Days -60 to -89).  The 
expected value for the chi-square calculation is based on the proportion of the specific 
product-adverse events relative to all product-adverse events for the prior 30 days (Days -
60 to -89 in the example above) compared to the observed data for the current 30 days.  If 
the chi-square test met the alert criteria in Table 6, the test was considered positive for a 
change in the data pattern.   
Modified Chi-square (Evan’s Criteria) 
In addition to a significant chi-square test, analysis described in the section above, 
Evan’s criteria add additional requirements intended to decrease the number of false 
positive results and increase specificity. First, the number of events in the current 30 day 
  73 
   
period must exceed 3. Second, the Proportionate Reporting Ratio (PRR) for this 30 day 
time period must exceed 2.  
The PRR is computed as: 
PRR  = 
(𝑐𝑜𝑐𝑛𝑡 𝑜𝑓 𝑠𝑒𝑒𝑐𝑖𝑓𝑖𝑐 𝐴𝐴_𝑒𝑟𝑜𝑝𝑐𝑐𝑡 𝑒𝑒𝑒𝑛𝑡𝑠)/(𝐴𝐴𝐴 𝑜𝑡ℎ𝑒𝑟 𝑒𝑒𝑒𝑛𝑡𝑠 𝑓𝑜𝑟 𝑡ℎ𝑖𝑠 𝑒𝑟𝑜𝑝𝑐𝑐𝑡)(𝑐𝑜𝑐𝑛𝑡𝑠 𝑜𝑓 𝑠𝑒𝑒𝑐𝑖𝑓𝑖𝑐 𝐴𝐴 𝑓𝑜𝑟 𝑎𝐴𝐴 𝑜𝑡ℎ𝑒𝑟 𝑒𝑟𝑜𝑝𝑐𝑐𝑡𝑠)/(𝑐𝑜𝑐𝑛𝑡𝑠 𝑜𝑓 𝑎𝐴𝐴 𝑜𝑡ℎ𝑒𝑟 𝑒𝑒𝑒𝑛𝑡𝑠 𝑓𝑜𝑟 𝑎𝐴𝐴 𝑜𝑡ℎ𝑒𝑟 𝑒𝑟𝑜𝑝𝑐𝑐𝑡𝑠) 
The PRR provides a measure of the degree to which the proportion of a specific adverse 
event for a specific product is unexpected given the proportion calculated for that adverse 
event for all other products in the database.  If all alert criteria in Table 6 are exceeded, 
the test is considered positive for a change in the data pattern. 
Control Charting 
As mentioned above, control charts are comprised of 2 key components, a 
measure of central tendency and a measure of variability.  For this study, the count of 
events for the most recent 30 days (i.e., for the analysis at Study Day -30, the most recent 
30 days previous to Day -30) was compared to the mean and standard deviation 
computed using data for the 24 months prior to the most recent 30 days.  The 24 months 
prior to the most recent 30 days included in the analysis provide data points for 
computation of the mean number of product-adverse event counts.  Twenty-four months 
was selected based upon the recommendations in engineering fields (Lee & McGreevey, 
2002).  If the count of events for the most recent 30 days exceeds the alert criteria in 
Table 6, the analysis is considered positive for a change in the data pattern.  
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Modified Control Charting (Western Electric Rules) 
The analysis proceeds in the same manner as the control charting analysis, but 
there are additional criteria to indicate a deviation in the pattern of data, thereby 
increasing sensitivity.  In addition to the criterion of product-adverse event count outside 
of mean + 3 standard deviations, a change in the pattern of data is indicated if 2 
consecutive data points are outside mean plus 2 standard deviations, if 4 out of 5 data 
points are beyond mean plus 1 standard deviation, or if 9 consecutive data points are 
greater than the mean. 
CUSUM Chart 
The computation of the CUSUM chart is similar to control chart methodology.  
The 24 months prior to the most recent 30 days included in the analysis provide data 
points for computation of the mean number of product-adverse event counts.  Twenty-
four months was selected based upon the recommendations in engineering fields (Lee & 
McGreevey, 2002).  This 24-month mean is the k-value in the CUSUM equation: 
𝑆𝑟 = �Xi − k𝑟
𝑖=1
 
The cumulative summation will proceed with 𝑆𝑟 taking the value: 
𝑆0=0 
 𝑆𝑟=max(0, 𝑆𝑟−1+𝑆𝑟) 
If the Sr value exceeds the alert criteria in Table 6, the analysis is considered positive for 
a change in the data pattern. 
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Bayesian EB05 
EB05 is the lower bound of the 95% confidence interval about the empirical 
Bayes geometric mean for the following ratio of ratios:  
(𝑐𝑜𝑐𝑛𝑡 𝑜𝑓 𝑠𝑒𝑒𝑐𝑖𝑓𝑖𝑐 𝐴𝐴−𝑒𝑟𝑜𝑝𝑐𝑐𝑡 𝑒𝑒𝑒𝑛𝑡𝑠)/(𝐴𝐴𝐴 𝑜𝑡ℎ𝑒𝑟 𝑒𝑒𝑒𝑛𝑡𝑠 𝑓𝑜𝑟 𝑡ℎ𝑖𝑠 𝑒𝑟𝑜𝑝𝑐𝑐𝑡)(𝑐𝑜𝑐𝑛𝑡𝑠 𝑜𝑓 𝑠𝑒𝑒𝑐𝑖𝑓𝑖𝑐 𝐴𝐴 𝑓𝑜𝑟 𝑎𝐴𝐴 𝑜𝑡ℎ𝑒𝑟 𝑒𝑟𝑜𝑝𝑐𝑐𝑡𝑠)/(𝑐𝑜𝑐𝑛𝑡𝑠 𝑜𝑓 𝑎𝐴𝐴 𝑜𝑡ℎ𝑒𝑟 𝑒𝑒𝑒𝑛𝑡𝑠 𝑓𝑜𝑟 𝑎𝐴𝐴 𝑜𝑡ℎ𝑒𝑟 𝑒𝑟𝑜𝑝𝑐𝑐𝑡𝑠) 
The calculation for EB05 shares many computational similarities with the PRR discussed 
above.  The key difference is that the PRR is a calculation of fixed proportions whereas 
the Bayesian methodology is based upon the ratio of two posterior distributions (the 
numerator and denominator, respectively).  The variability of these distributions increases 
or decreases depending upon the variability of the prior data.  If the lower bound of the 
90% confidence interval (EB05) is greater than the alert level in Table 6, the analysis 
indicated the numerator is significantly different from the denominator and, therefore, 
there is a change detected. 
Reliable Change Index (RCI) 
The methodology for RCI computation is similar to the computations for control 
charting and chi-square.  The standard error component, the denominator of the 
calculation, is computed from the monthly product-adverse event counts for the 24 
months previous to the most recent 30 days included in the analysis.  The numerator of 
the RCI is calculated as the difference in product-adverse event counts between the most 
recent 30 days (e.g., Day -29 to Day 0) and the most recent 30 days prior to that 30 day 
period (e.g., Day -59 to Day -30).  If the calculation of the RCI exceeds the alert criteria 
in Table 6, the analysis is considered positive for a change in the data pattern. 
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Change Point Regression 
Change point regression is a regression model with an additional parameter that 
fits a model before and after the change point.  The data for the 24 months prior to and 
including the 30 days under study were included in the regression analyses.  If the change 
point parameter was not significant, there was no change detected.  If the parameter was 
significant, there was a point where the data pattern changes and, essentially, the model 
had a better fit if the regression parameters were different before and after the change 
point.  If the change point parameter was significant at the threshold noted in Table 6, 
then the change point regression was positive for a change in the data pattern. Details of 
the SAS code used for this analysis are included in Appendix A. 
Each of these computations is applied to the analysis data set.  The data regarding 
alert or no alert is accumulated and compared to the data field indicating confirmed safety 
signals.  The comparison allows computation of sensitivity and specificity and, 
subsequently, AUC ROC.  
Computation of Sensitivity and Specificity at Day -30 
At the time point designated 30 days prior to a confirmed safety signal, data are 
analyzed using the methodologies in Table 6. The methodologies are run for all unique 
product-adverse event combinations.  Analyses which exceed the alert cutoff values 
above are scored Alert=1 in the database.  Where Alert=1 for a product-adverse event 
combination that is a confirmed safety signal, the result is true positive.  If Alert=1 but 
the product-adverse event combination is not a confirmed signal, the result is scored a 
false positive.  Where Alert ≠1 but the medical review noted a true safety signal, the 
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result is a false negative.  Finally, if Alert ≠1 and no safety signal identified, the result is 
a true negative.  This process is repeated for all analysis methodologies for all product-
adverse event combinations at Day -30. The combinations of true/false positives and 
true/false negatives provide the basis for computation of sensitivity and specificity. 
 After this procedure is completed for the alert cutoff values, the analysis is 
repeated for the alternate cutoff values for each methodology.  Employing the alternate 
cutoffs provides data to compute a series of sensitivity/specificity pairs, for each 
methodology at Day -30.  This collection of sensitivity and specificity pairs may be 
plotted to create a ROC curve, representing the performance of a given change detection 
methodology thirty days prior to a confirmed safety signal.  The area under this ROC 
curve will be computed using the trapezoidal rule.  The trapezoidal rule is a non-
parametric computation that treats the area under the sensitivity/specificity pairs as a 
series of triangles and rectangles, whose area is then summed to yield the total area under 
the ROC curve.  Figure 7 below shows the triangles and rectangles formed by the pairs of 
sensitivity and specificity points collected.   
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Figure 7. Application of the Trapezoidal Rule for Computation of Area Under the ROC 
 
Area equals (base x height) for the rectangles and ½(base x height) for the 
triangles.  The total ROC area is given by: 
Triangles: ∑
1
2
⌊(𝑠𝑒𝑛𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑖 − 𝑠𝑒𝑛𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑖−1) ∗ ((1 − 𝑠𝑒𝑒𝑠𝑠𝑓𝑠𝑠𝑠𝑠𝑠)𝑖 −5𝑖=1(1 − 𝑠𝑒𝑒𝑠𝑠𝑓𝑠𝑠𝑠𝑠𝑠)𝑖−1)⌋ 
Rectangles: ∑ ⌊(𝑠𝑒𝑛𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑖 − 𝑠𝑒𝑛𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑖−1) ∗ ((1 − 𝑠𝑒𝑒𝑠𝑠𝑓𝑠𝑠𝑠𝑠𝑠)𝑖 −5𝑖=2(1 − 𝑠𝑒𝑒𝑠𝑠𝑓𝑠𝑠𝑠𝑠𝑠)𝑖−1)⌋ 
where sensitivityi and specificityi are the sensitivity and specificity for alert cutoff i. If 
i=0, sensitivity and 1-specificity are equal to 0.  This is equivalent to assuming the test is 
always equal to ‘no signal’.  Additionally, the point 1,1 is assumed part of the ROC 
computation, which is achieved when the test is always equal to ‘signal’.  If the final 
sensitivity/specificity pair falls short of 1,1, the final area includes the area from the 4th 
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cutoff point to point 1,1.  The total area is given by the sum of rectangular and triangular 
areas. 
Sensitivity and Specificity at Days -29 to 0 
The process described for Day -30 is repeated for Days -29 to  Day 0. The result 
is 31 areas under the ROC curve for each change detection methodology.  Summing the 
31 areas and dividing by the number of measurements results in the mean AUC ROC.  
Methodologies which are highly sensitive and specific far in advance of the confirmed 
safety signal will result in mean AUC ROC near 1.0.  Poorly performing methodologies 
will have mean AUC ROC near 0.5. 
AUC ROC Line Graphs 
 During the course of analyzing data to examine differences in change detection 
methods, it became apparent that the originally proposed 3D ROC figures were not a 
useful method for comparing the performance of the candidate methodologies (see 
Appendix E, 3D ROC Analysis and Sample 3D ROC Graphs).  In fact, the 3D AUC 
ROCs were only able to distinguish performance between change detection 
methodologies when results were substantially different between methods.  Additionally, 
it was not possible to identify a time point where the change detection methods started to 
perform acceptably well (i.e., better than chance, AUC ROC>0.6) due to the complexity 
of those figures.  As a result of this short-coming, alternative graphical representations of 
the performance of the detection methods over time were examined.  Several graphs were 
considered before a line plot of the AUC ROC by day was selected (Heagerty, 2005; 
Zheng & Heagerty, 2004).  This graph has the benefit of allowing each method to be 
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plotted simultaneously on the same graph to facilitate comparisons. See Figure 8, sample 
AUC Line Graph, for an example of this method of comparison. 
 
 
Figure 8. Sample AUC ROC Line Graph 
 
As noted by Heagerty and his colleagues, the hypothetical range of this graph is 
from 0 to 1.0, with values below 0.5 achieved as the time between the gold standard 
outcome and the test result increases.  This data display clearly shows the differences in 
the AUC ROC by day, so the detection methods could be compared over time, from Day 
AUC ROC 
Days 
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-30 to Day 0.  As a result, the analyses below will include this line plot as the graphic 
representation to compare change detection methods rather than the 3D ROC. 
Secondary Analyses 
Secondary analyses were conducted to examine the robustness of the results.  
These analyses were conducted exactly in the manner described above for the primary 
analysis, but utilizing specific subsets of data.  For example, change detection sensitivity 
and specificity have been demonstrated to differ according to the volume of adverse 
events present for a given product-adverse event combination (Evans et al., 2001).  The 
analysis data set was divided into 3 subsets based upon the number of occurrences of the 
product-adverse event pair in the data set.  This resulted in 3 subsets: Most-frequent, mid-
frequent, and least-frequent pairs.  The analyses described above for the primary analysis 
were repeated for the three subsets of data and consistency of results examined. 
Due to the potential impact of the non-signal (foil distribution) data on the 
primary analysis, a sensitivity analysis was conducted by adjusting the Day 0 for the non-
signal data points.  Rather than June 1, 2013, Day 0 was randomly assigned for non-
signal product-adverse event to occur between January 1, 2013 and June 1, 2013.  These 
alternative Day 0s provided insight into the question of whether the non-target 
distribution affects calculations of sensitivity and specificity for the change detection 
methodologies.   
Additional exploratory analyses were conducted using all 3 of the factors for 
escalating safety issues (change in pattern, single report of medically significant event, 
and safety signal resulting from comparison to other similar drugs).  The reason for this 
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analysis is that the factors above are not completely independent.  For example, adverse 
event reporting may be trending upward moderately (and in-and-of-itself would not be 
remarkable) but the data may also include unusual or medically-interesting events (i.e., 
adverse events which required drug treatment to reverse) or the pattern may seem slightly 
different from other similar drugs. Both may lead to a determination of a safety signal 
when considering the three factors above simultaneously, but independently may not lead 
to a safety signal.  Therefore, it was necessary to examine analyses using these different 
factors. 
Analyses were conducted to examine the effect of eliminating the signal during 
the run-in period data on the interpretation of results.  In describing the data handling, a 
decision was made to eliminate data streams which included a signal in the run-in period 
(June 1, 2009 - June 1, 2011).  In order to examine the effect of excluding these 2,892 
pairs, a secondary analysis was conducted that includes these product-adverse event 
pairs.  Analysis of this data set proceeded in exactly the same manner as the primary 
analysis in order to facilitate comparison to the primary analysis results (thresholds were 
computed for each change detection method, presence or absence of each change 
computed, and sensitivity/specificity computed for Day -30 to Day 0).   
Finally, analyses were conducted to determine if the presence of a signal during 
the run-in period of data collection (June 1, 2009 – June 1, 2011) is predictive of a signal 
during the analysis period (June 1, 2011 – June 1, 2013).  The analysis included 22,150 
product-adverse event pairs, 2,892 of which include a signal during the run-in period.  
The analysis was conducted using a 2x2 table, signal present during run-in vs. no signal 
  83 
   
present during run-in and signal present during analysis period vs. no signal present 
during analysis period.  An odds ratio was computed to determine the relative increase or 
decrease in the odds of a signal during the analysis period given the presence of a signal 
during the run-in period.  A confidence interval for the odds ratio was computed to 
determine if the ratio is significantly different from 1.0 
Data Analysis and Predicted Results 
Data for the primary analysis and the subsets created for secondary analyses were 
summarized by mean values, range, and mean (95% CI) AUC ROC.  Consistency of 
results was examined by comparing sensitivities, specificities, mean AUC ROC and 95% 
confidence intervals for the primary analysis to the secondary (subsets) analyses.  One-
way ANOVA models followed by pairwise Tukey HSD analyses were conducted to 
determine if statistically significant differences exist between change detection methods.  
Prior to conducting the analysis, all AUC ROC values were arcsine transformed to 
transform the proportions to data more appropriate for the assumptions of ANOVA. All 
data for secondary analysis subsets were tabulated and analyzed in the same manner as 
the primary analysis to facilitate comparison of results.  
Predicted Results 
Based upon previous research, several hypotheses were tested in the present 
study:   
H1: Modified control charting will be more sensitive than control charting. 
H2: Modified chi-square will be more specific than chi-square. 
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These hypotheses were direct extension of the formulations of the modifications 
themselves.  Control charting was believed to be too insensitive to change, and therefore 
modifications, like the Western Electric Rules, were developed to address this 
shortcoming (King, 1996).  Similarly, chi-square tests were too sensitive in the field of 
healthcare safety surveillance, so modifications were created to increase the specificity 
(King, 1996; Corbett & Pan, 2002; Evans, Waller, & Davis 2001).  Similarly, previous 
research also suggested relationships between Bayesian and CUSUM methods. 
H3: Bayesian and CUSUM methods will not be statistically significantly different 
based upon mean AUC ROC. 
Literature in the public health and safety surveillance fields of study suggests that these 
methods perform equivalently based upon sensitivity and specificity (Chen et al., 2008; 
Chen et al. 2011), though no prior work examined these methods across various cutoffs in 
order to compare their performance based upon AUC ROC.   
H4: CUSUM and change point regression methods will not be statistically 
significantly different based upon mean AUC ROC. 
CUSUM and change point regression methods share a commonality of computation – the 
use of the Poisson distribution in their formulation. Given that the simulated data and 
actual data are collections of Poisson distributed variables, these methods were expected 
to perform well and should perform equivalently to each other (Rossi, Lampugnani, & 
March, 1999; Riffenburgh & Cummins, 2006).   
 Hypotheses H1 – H4 were tested by one-way ANOVA of the mean AUC ROC 
values for each method. If the ANOVA result was statistically significant (p<0.05), a 
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Tukey HSD test was conducted to examine significant pairwise differences.  It was 
expected that there would be pairwise differences between control charting and modified 
control charting and chi-square and modified chi-square (H1 and H2).  It was expected 
that there would not be significant differences between Bayesian and CUSUM and 
CUSUM and change point regression (H3 and H4).  
 For hypotheses H1-H4, there is ample evidence within the literature to provide 
confidence that these hypotheses will be supported by the present study.  Where current 
literature is lacking, however, is evidence to suggest the relative performance of measures 
across disciplines. For example, comparing RCI, a social science measure, relative to 
control charting, an engineering measure, to Bayesian analysis, a method from healthcare 
(Woodall, 2006).  However, extrapolation based upon literature within each field of study 
suggests the following hypotheses: 
H5: RCI will perform better than all healthcare change detection methods (i.e., 
Bayesian, chi-square, and modified chi-square) based upon mean AUC ROC. 
The RCI method has a long history of development within psychological science (Ogles, 
Lunnen, & Bonesteel, 2001).  Additionally, authors with experience in both 
epidemiology and psychological science have advocated the more broad use of RCI to 
detect a reliable change in patterns of data (Kemmler et al., 2010).   
The hypothesized performance of engineering methodologies relative to 
healthcare methodologies may be stated:  
  86 
   
H6: Control charting and modified control charting will perform better than all 
healthcare change detection methods (i.e., Bayesian, chi-square, and modified chi-
square) based upon mean AUC ROC. 
As with hypothesis H5, there is limited information regarding this direct comparison.  
Authors familiar with both methodologies have suggested that control charting and 
modified control charting could improve the ability of health care change detection 
methodology (Almenoff et al., 2007; Stoumbos, Reynolds, & Woodall, 2003; Bate & 
Reynolds, 2010).   
Hypotheses H5 and H6 were tested by one-way ANOVA of the mean AUC ROC 
values for each method. If the ANOVA result was statistically significant (p<0.05), a 
Tukey HSD test was conducted to examine significant pairwise differences.  Significant 
pairwise differences will be examined to support or refute the stated hypotheses  
Additionally, it was expected that secondary analyses will substantiate the results 
of the primary analysis.  The simulated data were intended to mimic the actual data.  
Specifically, the moderate effect simulated data would mimic the actual data, and the 
strong- and weak-effect simulated data were intended to examine results based on data 
more extreme than the moderate-effect data set. Based upon the conditions under which 
data were generated, the following hypothesis was examined in the present study related: 
H7: Results from analyses of simulated data will mimic the primary analysis 
results. 
Evidence of hypothesis H7 would support more broad generalization of observed results.  
Authors have noted that the performance of change detection methods may be data-
  87 
   
dependent, at least where quantities of data are limited, so evidence that detection method 
performance is consistent with both simulated and actual data would support a use of 
these methodologies across numerous data collection applications (Hauben et al. 2005; 
Hauben, 2007; Matsushita et al., 2007).  Evidence of similarity between the primary 
analysis and analysis based upon simulated data will be determined by examination of 
sensitivity, specificity, and mean AUC ROC values as well as the ANOVA and Tukey 
analyses comparing the change detection methodologies.   
Quality Control 
 From the point of data entry to data extraction, analysis, and summarization, high 
data quality standards were maintained.  The customer care center maintained complete, 
audit-trailed records for each call received.  Then, trained medical personnel reviewed 
each adverse event for indications that a potential safety signal existed. Prior to escalation 
to management, the adverse events were reviewed by senior medical personnel for 
confirmation of the safety signal.  Programs that extracted data for analysis were 
programmed twice and resulting data sets compared to insure consistency of the extracted 
data.  Analysis programs were written primarily using SAS code.  Quality checks were 
conducted to verify input/output data sets and product-adverse event counts using 
Microsoft Excel and SAS/JMP. 
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RESULTS 
 Results for the three simulated data set analyses, the primary analysis, and 
secondary subset analyses will follow the same format for ease of review: 
1. Table of descriptive statistics summarizing the sensitivity, specificity, and 
mean AUC ROC values. 
2. ANOVA results examining statistical differences between the change 
detection methodologies based upon the mean AUC ROC computed for each 
method.  Prior to conducting the analysis, all AUC ROC values will be arcsine 
transformed to transform the proportions to data more appropriate for the 
assumptions of ANOVA.  
3. Line graph comparison of the AUC ROC by day, to facilitate comparison of 
the change detection methods over time. 
Results will be presented for the simulated data sets first, followed by the primary 
analysis of the consumer call center data, then finally for the secondary analysis subsets.  
Results of the primary analysis and secondary subsets will be compared to examine the 
robustness of the results.  Histograms of the distribution of signal and no-signal monthly 
adverse event counts are presented for the 3 simulated data sets and the primary analysis 
data set in Appendix F. 
Simulation Results 
Results for analyses conducted on the 3 simulated data sets (weak effect, 
moderate effect, and strong effect sizes) are summarized in Tables 7 through 9 below. 
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Table 7. Results for the Simulated Data Analysis, Weak Effect Size 
Methodology Sensitivity 
Mean  
(SD) 
Specificity 
Mean  
(SD) 
AUC 
ROC 
Mean  
(95% CI)  
Chi-Square 0.54 
(0.39) 
0.66 
(0.32) 
0.76 
(0.70-0.82) 
Modified Chi-square (Evan’s Criteria) 0.14 
(0.20) 
0.97 
(0.05) 
0.63 
(0.58-0.66) 
Control Charting 0.40 
(0.37) 
0.81 
(0.23) 
0.71 
(0.65-0.77) 
Modified Control Charting (Western Electric 
Rules) 
0.81 
(0.30) 
0.26 
(0.31) 
0.87 
(0.80-0.93) 
CUSUM 0.63 
(0.38) 
0.59 
(0.32) 
0.81 
(0.74-0.88) 
Bayesian 0.67 
(0.37) 
0.49 
(0.35) 
0.82 
(0.75-0.88) 
RCI 0.73 
(0.36) 
0.35 
(0.34) 
0.82 
(0.74-0.90) 
Change Point Regression 0.44 
(0.38) 
0.81 
(0.21) 
0.75 
(0.69-0.82) 
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Table 8. Results for the Simulated Data Analysis, Moderate Effect Size 
Methodology Sensitivity 
Mean  
(SD) 
Specificity 
Mean  
(SD) 
AUC 
ROC 
Mean  
(95% CI) 
Chi-Square 0.63 
(0.41) 
0.56 
(0.37) 
0.77 
(0.72-0.83) 
Modified Chi-square (Evan’s Criteria) 0.27 
(0.32) 
0.93 
(0.12) 
0.64 
(0.59-0.70) 
Control Charting 0.52 
(0.41) 
0.71 
(0.31) 
0.73 
(0.67-0.79) 
Modified Control Charting (Western Electric 
Rules) 
0.84 
(0.29) 
0.23 
(0.30) 
0.88 
(0.81-0.94) 
CUSUM 0.70 
(0.39) 
0.47 
(0.36) 
0.82 
(0.76-0.89) 
Bayesian 0.73 
(0.37) 
0.41 
(0.37) 
0.82 
(0.76-0.89) 
RCI 0.75 
(0.37) 
0.31 
(0.35) 
0.83 
(0.76-0.90) 
Change Point Regression 0.57 
(0.41) 
0.69 
(0.31) 
0.78 
(0.71-0.84) 
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Table 9. Results for the Simulated Data Analysis, Strong Effect Size 
Methodology Sensitivity 
Mean  
(SD) 
Specificity 
Mean  
(SD) 
AUC 
ROC 
Mean  
(95% CI) 
Chi-Square 0.68 
(0.40) 
0.66 
(0.32) 
0.80 
(0.75-0.86) 
Modified Chi-square (Evan’s Criteria) 0.33 
(0.36) 
0.97 
(0.05) 
0.69 
(0.62-0.75) 
Control Charting 0.58 
(0.42) 
0.81 
(0.23) 
0.76 
(0.70-0.82) 
Modified Control Charting (Western Electric 
Rules) 
0.86 
(0.30) 
0.26 
(0.30) 
0.89 
(0.83-0.95) 
CUSUM 0.76 
(0.37) 
0.59 
(0.32) 
0.85 
(0.79-0.91) 
Bayesian 0.77 
(0.36) 
0.49 
(0.35) 
0.85 
(0.79-0.91) 
RCI 0.79 
(0.35) 
0.35 
(0.34) 
0.85 
(0.79-0.92) 
Change Point Regression 0.65 
(0.41) 
0.81 
(0.21) 
0.82 
(0.75-0.88) 
 
Recall that the three simulated data sets differ only in the strength of the signal 
data included in the simulation (from a weak signal to strong signal).  The weak signal 
analysis revealed that modified control charting performs well over the 31 day range 
(mean AUC ROC=0.87).  Modified chi-square, control chart, and change point regression 
were the most specific methods (mean specificity=0.97, 0.81, and 0.81 respectively).  
Modified control charting and RCI were the most sensitive, mean sensitivity=0.81 and 
0.73, respectively.  Consistent with H1 and H2, modified chi-square was more specific 
than chi-square - the modifications were specifically intended to increase specificity 
(Evans, Waller, & Davis, 2001). Conversely, modified control charting was more 
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sensitive than control chart - in this case the modifications were intended to increase 
sensitivity (King, 1995).  
 Results for moderate and strong effects were consistent with the analyses of the 
weak effect data set.  Comparisons between the weak to strong effect size data sets 
revealed no changes in the relative performance of the change detection methods.  
Modified control charting maintained strong performance overall as indicated by mean 
AUC ROC (0.88 and 0.89 for moderate and strong effect size data sets, respectively).   
Across the three data sets, differences between methods remained relatively constant as 
indicated by the mean AUC ROC, though as expected the values for AUC ROC 
increased for all methods as the strength of the effect to be detected increased.   
 ANOVA results indicated significant differences in performance between the 
change detection methods, and the pattern of significant results changed slightly between 
the weak to strong effect size data sets.  Note that for each of the eight methods, there are 
31 AUC ROC values, one for each of the study days, resulting in 8x31=248 degrees of 
freedom.  For all three data sets, ANOVA results indicated a statistically significant 
difference between mean AUC ROC among the eight methods, F(7, 240)=7.27, F(7, 
240)=7.91, F(7, 240)=6.64, all p<0.001, for weak, moderate, and strong effects, 
respectively.  To determine the source of the significant results, a subsequent Tukey HSD 
analysis was conducted to examine significant pairwise differences. For the weak, 
moderate, and strong effect data sets, the significant differences, p<0.05, between 
methods are summarized in Table 10. 
  
  93 
   
 
Table 10. Significant Differences between Methods, Simulated Data 
Weak Effect Moderate Effect Strong Effect 
1. Modified Control 
Charting 
1. Modified Control 
Charting 
1. Modified Control 
Charting,  
RCI  
 
2. RCI 2. RCI 2. Bayesian, 
CUSUM, 
Change Point 
Regression, 
3. Bayesian, 
CUSUM 
3. Bayesian, 
CUSUM 
3. Chi-Square, 
Control Charting 
4. Chi-Square, 
Change Point 
Regression 
 
4. Chi-Square, 
Change Point 
Regression 
 
4. Modified Chi-
Square 
5. Control Charting 5. Control Charting  
6. Modified Chi-
Square 
6. Modified Chi-
Square 
 
Note: Methods in one row have a statistically significantly greater mean AUC ROC than 
methods listed on rows below for a given effect size. Methods listed in the same cell are 
not significantly different from one another 
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In terms of mean AUC ROC, the modified control charting method was superior 
to all other methods for the weak and moderate effect size data sets.  Additionally, 
modified chi-square performed statistically significantly worse than all other methods for 
all simulated data sets. For the strong effect, RCI, CUSUM, and Bayesian methods were 
not significantly different from one another.  Listed just below these methods, chi-square 
and control charting analyses were not statistically different from one another, but they 
performed significantly better than modified chi-square. 
 Graphically, these differences can be summarized with the following line graphs, 
Figures 9a through 9c for the weak through strong simulated data sets.  These graphs 
represent the data collection for the 30 days prior to the day of the confirmed signal, Day 
0.  On each day, the AUC ROC is computed for each method based upon the sensitivity 
and specificity calculations for the various cutoffs employed (refer to Table 6 for cut off 
values employed for each method).  The resulting plots show the effect of time and 
accumulation of data on the performance of each method. 
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Figure 9. AUC ROC Plotted by Days -30 to Day 0, Simulated Data,  
Weak Effect Size  
   
AUC ROC 
Days 
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Figure 10. AUC ROC Plotted by Days -30 to Day 0, Simulated Data,  
Moderate Effect Size 
  
Days 
AUC ROC 
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Figure 11. AUC ROC Plotted by Days -30 to Day 0, Simulated Data,  
Strong effect size 
 
Given that an AUC ROC of 0.5 represents chance performance, the extent to 
which methods move above the 0.5 line as early as possible indicates desirable 
performance:  early detection of potential safety signals.  In order to illustrate the value of 
the line graph to reveal differences in the time to detect a signal reliably, consider an 
arbitrary point on the y-axis, 0.6.  To illustrate the interpretation of the line graphs, 
consider Figure 12, AUC ROC Comparison of Weak and Strong Effects, highlighting the 
performance of control chart methodology, the solid purple line.  As an example, 
Days 
AUC ROC 
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consider the point at which control chart reached mean AUC ROC=0.6.  This point was 
achieved at approximately Day -23 in the strong effect graph and Day -21 in the weak 
effect graph.  Essentially, the control chart methodology was reliably informative 2 days 
earlier when the effect to be detected was strong rather than weak.   
 
 
 
Figure 12. AUC ROC Comparison of Weak and Strong Effects  
 
Weak 
 
 
Strong 
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Primary Analysis 
The primary analysis, comparison of the change detection methodologies using 
actual data collected from the consumer safety database, was conducted using the same 
approach applied to the simulated data.  Sensitivity, specificity, and mean AUC ROC are 
summarized below in Table 11, Results for the Primary Analysis, Actual Data. 
 
Table 11. Results for the Primary Analysis, Actual Data 
Methodology Sensitivity 
Mean  
(SD) 
Specificity 
Mean  
(SD) 
AUC 
ROC 
Mean  
(95% CI) 
Chi-Square 0.58 
(0.41) 
0.56 
(0.37) 
0.72 
(0.65-0.79) 
Modified Chi-square (Evan’s Criteria) 0.20 
(0.26) 
0.93 
(0.11) 
0.58 
(0.55-0.62) 
Control Charting 0.46 
(0.40) 
0.71 
(0.31) 
0.67 
(0.62-0.72) 
Modified Control Charting (Western Electric 
Rules) 
0.82 
(0.31) 
0.23 
(0.30) 
0.85 
(0.77-0.92) 
CUSUM 0.69 
(0.39) 
0.47 
(0.36) 
0.80 
(0.73-0.87) 
Bayesian 0.69 
(0.39) 
0.41 
(0.37) 
0.79 
(0.72-0.86) 
RCI 0.73 
(0.37) 
0.31 
(0.35) 
0.80 
(0.72-0.88) 
Change Point Regression 0.54 
(0.41) 
0.69 
(0.31) 
0.74 
(0.67-0.80) 
 
The primary analysis revealed patterns that are similar to the simulated data 
results for the moderate effect size.  Modified control charting performed well over the 
31-day range (mean AUC ROC=0.85).  Modified chi-square, control chart, and change 
point regression were the most specific methods (mean specificity=0.93, 0.71, and 0.69, 
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respectively).  Modified control charting and RCI were the most sensitive (mean 
sensitivity=0.82 and 0.73, respectively).  The sensitivity of CUSUM and Bayesian lagged 
slightly behind, with mean sensitivities of 0.69.   
 ANOVA results indicated significant differences in performance between the 
change detection methods.  One-way ANOVA results indicated a statistically significant 
difference between mean AUC ROC among the eight methods F(7, 240)=8.81, p<0.001.  
To determine the source of the significant results, a subsequent Tukey HSD analysis was 
conducted to examine significant pairwise differences. The significant differences 
(p<0.05) between methods are summarized in Table 12 below. 
 
Table 12. Significant Differences between Methods, Primary Analysis  
Method 
1. Modified Control Charting 
2. RCI, Bayesian, CUSUM 
3. Chi-Square, Change Point 
Regression 
4. Control Charting 
5. Modified Chi-Square 
Note:  Methods in one row have a statistically significantly greater mean AUC ROC than 
methods listed on rows below. Methods listed in the same cell are not significantly 
different from one another 
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As with the simulated data, modified control charting performed statistically significantly 
better than other methods and the modified chi-square performed significantly worse, as 
measured by mean AUC ROC. 
Graphically, these differences are summarized with the following line graph, 
Figure 13.  This graph represents the data collection for the 30 days prior to the day of the 
confirmed signal, Day 0.  On each day, the AUC ROC was computed for each method 
based upon the sensitivity and specificity calculations for the various cutoffs employed 
(refer to Table 6 for cutoff values employed for each method).  The resulting plots show 
the effect of time and accumulation of data on the performance of each method. 
 
 
Figure 13. AUC ROC Comparison of Change Detection Methods by Day, Primary 
Analysis  
AUC ROC 
Days 
  102 
   
 
Secondary Analysis – Product Volume 
Several secondary analyses were conducted to examine the effects of certain 
subsets of data on the overall conclusions.  First, change detection sensitivity and 
specificity have been demonstrated to differ according to the volume of adverse events 
present for a given product-adverse event combination (Evans, Waller, & Davis, 2001).  
Therefore, the primary analysis data set was divided into 3 subsets based upon the 
number of occurrences of the product-adverse event pairs in the data set.  The 19,258 
product-adverse event pairs were divided into 3 subsets: Most-frequent (n=6,540 pairs), 
mid-frequent (n=6,323 pairs), and least-frequent (n=6,395 pairs) based upon the total 
number of reports during the run-in period.  The primary analysis was repeated for the 
three subsets of data and consistency of results examined.  Table 13, Analysis of Most 
Frequent Product-Adverse Event Pairs, summarizes the sensitivity, specificity, and mean 
AUC ROC for the most frequently occurring pairs. 
  
  103 
   
Table 13. Analysis of Most-Frequent Product-Adverse Event Pairs 
Methodology Sensitivity 
Mean  
(SD) 
Specificity 
Mean  
(SD) 
AUC 
ROC 
Mean  
(95% CI) 
Chi-Square 0.59 
(0.41) 
0.56 
(0.37) 
0.73 
(0.66-0.79) 
Modified Chi-square (Evan’s Criteria) 0.19 
(0.26) 
0.93 
(0.11) 
0.58 
(0.55-0.61) 
Control Charting 0.46 
(0.40) 
0.71 
(0.31) 
0.67 
(0.62-0.72) 
Modified Control Charting (Western Electric 
Rules) 
0.82 
(0.31) 
0.22 
(0.30) 
0.85 
(0.78-0.92) 
CUSUM 0.69 
(0.39) 
0.47 
(0.36) 
0.80 
(0.74-0.88) 
Bayesian 0.69 
(0.38) 
0.41 
(0.36) 
0.79 
(0.72-0.87) 
RCI 0.74 
(0.37) 
0.31 
(0.35) 
0.81 
(0.72-0.89) 
Change Point Regression 0.54 
(0.41) 
0.69 
(0.31) 
0.74 
(0.67-0.81) 
 
ANOVA results indicate significant differences in performance between the 
change detection methods for the most-frequent product-adverse event pairs.  One-way 
ANOVA results indicate a statistically significant difference between mean AUC ROC 
among the eight methods, F(7, 240) = 9.08, p<0.001.  To determine the source of the 
significant results, a subsequent Tukey HSD analysis was conducted to examine 
significant pairwise differences. The significant differences (p<0.05) between methods 
are summarized in Table 14 below. 
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Table 14. Significant Differences between Methods, Most-Frequent Product-Adverse 
Event Pairs 
Most Frequent Analysis Results 
1. Modified Control Charting 
2. RCI, Bayesian, CUSUM,  
Change Point Regression,  
Chi-square 
3. Control Charting 
4. Modified Chi-Square 
Note:  Methods in one row have a statistically significantly greater mean AUC ROC than 
methods listed on rows below. Methods listed in the same cell are not significantly 
different from one another 
 
The pattern of results observed is similar to that of the primary analysis.  
Modified control charting performed significantly better than all other methods.  RCI, 
Bayesian, and CUSUM were not significantly different from change point regression and 
chi-square, as these methods were for the primary analysis.  Modified chi-square 
performed significantly worse than all other methods. 
 The pattern of results represented by the line graph is similar to that of the 
primary analysis, as might be expected from the ANOVA results summarized above.  
Figure 14 shows the effect of time and accumulation of data on the performance of each 
method for the most frequent adverse event pairs. 
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Figure 14. AUC ROC Comparison of Change Detection Methods by Day, Most-Frequent 
Product-Adverse Event Pairs 
 
The analyses were repeated for the mid-frequent and least-frequent product-
adverse event pairs to examine consistency of results.   
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Table 15. Analysis of Mid-Frequent Product-Adverse Event Pairs 
Methodology Sensitivity 
Mean  
(SD) 
Specificity 
Mean  
(SD) 
AUC 
ROC 
Mean  
(95% CI) 
Chi-Square 0.58 
(0.41) 
0.56 
(0.37) 
0.72 
(0.65-0.79) 
Modified Chi-square (Evan’s Criteria) 0.20 
(0.27) 
0.93 
(0.11) 
0.59 
(0.55-0.62) 
Control Charting 0.46 
(0.40) 
0.71 
(0.31) 
0.67 
(0.62-0.72) 
Modified Control Charting (Western Electric 
Rules) 
0.81 
(0.32) 
0.23 
(0.30) 
0.84 
(0.77-0.92) 
CUSUM 0.68 
(0.40) 
0.47 
(0.36) 
0.80 
(0.73-0.87) 
Bayesian 0.68 
(0.39) 
0.41 
(0.37) 
0.79 
(0.71-0.86) 
RCI 0.73 
(0.38) 
0.31 
(0.35) 
0.80 
(0.71-0.88) 
Change Point Regression 0.54 
(0.41) 
0.69 
(0.31) 
0.74 
(0.67-0.80) 
 
One-way ANOVA results indicated a statistically significant difference between 
mean AUC ROC among the eight methods for the analysis of mid-frequent product-
adverse event pairs, F(7, 240) = 8.32, p<0.001.  To determine the source of the significant 
results, a subsequent Tukey HSD analysis was conducted to examine significant pairwise 
differences. The significant differences (p<0.05) between methods are summarized in 
Table 16 below.  
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Table 16. Significant Differences between Methods, Mid-Frequent Product-Adverse 
Event Pairs 
Method 
1. Modified Control Charting 
2. RCI, Bayesian , CUSUM 
3. Chi-Square, 
 Change Point Regression 
4. Control Charting  
5. Modified Chi-Square 
Note:  Methods in one row have a statistically significantly greater mean AUC ROC than 
methods listed on rows below. Methods listed in the same cell are not significantly 
different from one another 
 
The pattern of results observed differed only slightly from that of the most-
frequent product-adverse event pairs and is the same as the pattern observed for the 
primary analysis.  RCI, Bayesian, and CUSUM were significantly different from change 
point regression and chi-square, whereas no difference was detected in the most-frequent 
product-adverse event pairs analysis.  As with previous analyses, modified control 
charting outperformed all other methods.  Modified chi-square performed statistically 
significantly worse than all other methods based upon mean AUC ROC. 
 The line graph of AUC ROC by day shows the pattern of results indicated by the 
ANOVA analyses.  The line graph shows the consistency of RCI, Bayesian, CUSUM, 
and change point regression methods and the virtually overlapping change point 
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regression and chi-square lines.  The accumulated data are summarized in Figure 15 
below. 
 
 
Figure 15. AUC ROC Comparison of Change Detection Methods by Day, Mid-Frequent 
Product-Adverse Event Pairs 
 
Table 17, Analysis of Least-Frequent Product-Adverse Event Pairs, summarizes 
the sensitivity, specificity, and mean AUC ROC for the product-adverse event pairs 
which occur least frequently in the safety database.  
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Table 17. Analysis of Least-Frequent Product-Adverse Event Pairs 
Methodology Sensitivity 
Mean  
(SD) 
Specificity 
Mean  
(SD) 
AUC 
ROC 
Mean  
(95% CI) 
Chi-Square 0.58 
(0.41) 
0.56 
(0.37) 
0.72 
(0.65-0.79) 
Modified Chi-square (Evan’s Criteria) 0.20 
(0.27) 
0.93 
(0.11) 
0.58 
(0.55-0.62) 
Control Charting 0.46 
(0.40) 
0.71 
(0.31) 
0.67 
(0.61-0.72) 
Modified Control Charting (Western Electric 
Rules) 
0.82 
(0.31) 
0.22 
(0.30) 
0.85 
(0.77-0.92) 
CUSUM 0.69 
(0.39) 
0.47 
(0.36) 
0.80 
(0.74-0.87) 
Bayesian 0.68 
(0.39) 
0.41 
(0.37) 
0.79 
(0.72-0.86) 
RCI 0.73 
(0.37) 
0.31 
(0.35) 
0.80 
(0.72-0.88) 
Change Point Regression 0.54 
(0.41) 
0.69 
(0.31) 
0.74 
(0.67-0.80) 
 
One-way ANOVA results revealed a statistically significant difference between 
change detection methods for the least-frequent product-adverse event pairs based upon 
the mean AUC ROC, F(7, 240) = 8.93, p<0.001.  A subsequent Tukey HSD analysis was 
conducted to examine significant pairwise differences. The significant differences 
(p<0.05) between methods are summarized in Table 18 below.  
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Table 18. Significant Differences between Methods, Least-Frequent Product-Adverse 
Event Pairs 
Method 
1. Modified Control Charting 
2. RCI, Bayesian , CUSUM 
3. Chi-Square,  
Change Point Regression 
4. Control Charting 
5. Modified Chi-Square 
Note:  Methods in one row have a statistically significantly greater mean AUC ROC than 
methods listed on rows below. Methods listed in the same cell are not significantly 
different from one another 
 
The pattern of results for the least-frequent product-adverse event pairs was the 
same as the pattern for the most and mid-frequent product-adverse event pairs.  Modified 
control charting performed significantly better, in terms of mean AUC ROC, than all 
other methods.  RCI, Bayesian, and CUSUM performed better than chi-square, change 
point regression, control charting and modified chi-square. 
Figure 16 summarizes the AUC ROC by day for the eight change detection 
methods.  The pattern of results was consistent with the pattern indicated by the one-way 
ANOVA results. 
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Figure 16. AUC ROC Comparison of Change Detection Methods by Day, Least-Frequent 
Product-Adverse Event Pairs 
 
Secondary Analysis - Quality Signal Data Included 
For the primary analysis, data were selected based upon the presence of a 
quantitative signal.  In the safety surveillance system, there are also signals identified that 
were not characterized as quantitative signals.  These data may have been declared 
signals because the quality of the data (the type or intensity of the reported events) 
indicated a potential safety concern to the physician responsible for the respective 
products.  This is a methodology in safety surveillance which is typically used to identify 
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signals that do not reach a quantitative level of interest.  In order to assess changes to 
interpretation of the primary analysis as well as provide a more real-world comparison of 
methodologies, the data containing quality signals were included in a secondary analysis.  
The analysis below was conducted with the 19,258 product-adverse event pairs but 
contained an additional 446 identified signals, for a total of 2,952 safety signals, 
compared to 2,506 safety signals in the primary analysis.   
Table 19, Analysis of Data Including the Quality Signal Data, summarizes the 
sensitivity, specificity, and mean AUC ROC for the change detection methods. 
 
Table 19.  Analysis of Data Including the Quality Signal Data 
Methodology Sensitivity 
Mean  
(SD) 
Specificity 
Mean  
(SD) 
AUC 
ROC 
Mean  
(95% CI) 
Chi-Square 0.60 
(0.40) 
0.56 
(0.37) 
0.74 
(0.67-0.80) 
Modified Chi-square (Evan’s Criteria) 0.25 
(0.30) 
0.93 
(0.11) 
0.61 
(0.57-0.66) 
Control Charting 0.49 
(0.40) 
0.71 
(0.31) 
0.69 
(0.64-0.74) 
Modified Control Charting (Western Electric 
Rules) 
0.83 
(0.30) 
0.23 
(0.30) 
0.86 
(0.79-0.93) 
CUSUM 0.70 
(0.37) 
0.47 
(0.36) 
0.81 
(0.75-0.87) 
Bayesian 0.71 
(0.37) 
0.41 
(0.37) 
0.80 
(0.74-0.87) 
RCI 0.74 
(0.36) 
0.31 
(0.35) 
0.81 
(0.74-0.89) 
Change Point Regression 0.56 
(0.39) 
0.69 
(0.31) 
0.75 
(0.69-0.81) 
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When compared to the results of the primary analysis, these results differed only 
moderately.  In terms of the mean AUC ROC, all values in Table 19 were equal to or 
slightly higher (0.01-0.02 higher) than the mean AUC ROC values for the primary 
analysis. 
One-way ANOVA results indicated a statistically significant difference between 
mean AUC ROC among the eight methods, F(7, 240) = 8.68, p<0.001.  To determine the 
source of the significant results, a subsequent Tukey HSD analysis was conducted to 
examine significant pairwise differences. The significant differences (p<0.05) between 
methods are summarized in Table 20 below. 
 
Table 20. Significant Differences between Methods, Analysis Including the Quality 
Signal Data  
Method 
1. Modified Control Charting 
2. RCI, Bayesian , CUSUM,  
3. Change Point Regression,  
Chi-Square 
4. Control Charting 
5. Modified Chi-Square 
Note:  Methods in one row have a statistically significantly greater mean AUC ROC than 
methods listed on rows below. Methods listed in the same cell are not significantly 
different from one another 
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The pattern of results indicated by the Tukey HSD test was the same pattern as 
the pattern for the previous secondary analysis and slightly different from the pattern for 
the primary analysis.  RCI, Bayesian, and CUSUM methods outperformed all other 
methods, except modified control charting.  Modified control charting performed 
statistically significantly better than the other methods and the modified chi-square 
performed significantly worse, as measured by mean AUC ROC. 
 The line graph of AUC ROC by day shows the pattern of results indicated by the 
ANOVA analyses.  The line graph shows the superiority of modified control charting and 
the consistency of RCI, Bayesian, and CUSUM methods.  The accumulated data are 
summarized in Figure 17 below. 
 
  
Figure 17. AUC ROC Comparison of Change Detection Methods by Day, Analysis 
Including the Quality Signal Data 
AUC ROC 
Days 
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Secondary Analysis - Random Day 0 
For the primary analysis, data without a signal were assigned June 1, 2013 as Day 
0.  The decision was arbitrary, but similar to how analyses of safety surveillance data 
would be conducted in practice.  Typically, in the evaluation of safety signals, an 
arbitrary cutoff day is selected for the most recent data to be included.  In order to insure 
the selection of a Day 0 for the noise distribution did not affect the interpretability of the 
primary analysis, a secondary analysis was conducted after assigning Day 0 at random 
within the noise distribution.    
Table 21, Analysis of Data Using Random Day 0 in the Noise Distribution, 
summarizes the sensitivity, specificity, and mean AUC ROC for the change detection 
methods. 
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Table 21.  Analysis of Data Using Random Day 0 in the Noise Distribution 
Methodology Sensitivity 
Mean  
(SD) 
Specificity 
Mean  
(SD) 
AUC 
ROC 
Mean  
(95% CI) 
Chi-Square 0.63 
(0.41) 
0.56 
(0.37) 
0.76 
(0.70-0.83) 
Modified Chi-square (Evan’s Criteria) 0.28 
(0.33) 
0.93 
(0.12) 
0.63 
(0.59-0.68) 
Control Charting 0.46 
(0.40) 
0.71 
(0.31) 
0.72 
(0.66-0.78) 
Modified Control Charting (Western Electric 
Rules) 
0.84 
(0.30) 
0.22 
(0.30) 
0.87 
(0.80-0.94) 
CUSUM 0.74 
(0.38) 
0.47 
(0.37) 
0.84 
(0.78-0.90) 
Bayesian 0.73 
(0.38) 
0.41 
(0.37) 
0.83 
(0.75-0.90) 
RCI 0.76 
(0.36) 
0.31 
(0.35) 
0.83 
(0.75-0.90) 
Change Point Regression 0.61 
(0.42) 
0.68 
(0.31) 
0.78 
(0.71-0.85) 
 
When compared to the results of the primary analysis, these results differed only 
slightly.  In terms of the mean AUC ROC, all values in Table 21 differed from the 
primary analysis mean AUC ROC by 0.02-0.04. 
One-way ANOVA results indicated a statistically significant difference between 
mean AUC ROC among the eight methods, F(7, 240) = 7.59, p<0.001.  To determine the 
source of the significant results, a subsequent Tukey HSD analysis was conducted to 
examine significant pairwise differences. The significant differences (p<0.05) between 
methods are summarized in Table 22 below. 
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Table 22. Significant Differences between Methods, Analysis Using Random Day 0 in 
the Noise Distribution  
Method 
1. Modified Control Charting 
2. RCI, Bayesian, CUSUM 
3. Chi-Square,  Change Point 
Regression 
4. Control Charting 
5. Modified Chi-Square 
Note:  Methods in one row have a statistically significantly greater mean AUC ROC than 
methods listed on rows below. Methods listed in the same cell are not significantly 
different from one another 
 
The pattern of results observed for the Random Day 0 analysis was same as the 
pattern of results observed for the primary analysis.  Modified control charting performed 
statistically significantly better than other methods and the modified chi-square 
performed significantly worse, as measured by mean AUC ROC. RCI, Bayesian, and 
CUSUM were not significantly different from each other.  Modified chi-square 
performed statistically significantly worse than all other methods based upon mean AUC 
ROC. 
 The line graph of AUC ROC by day depicts the pattern of results indicated by the 
ANOVA analyses.  The line graph shows the consistency of RCI, Bayesian, and CUSUM 
methods.  The accumulated data are summarized in Figure 18 below. 
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Figure 18.  AUC ROC Comparison of Change Detection Methods by Day, Analysis 
Using Random Day 0 in the Noise Distribution 
 
Secondary Analysis - Run-in Signal Data  
For the primary analysis, data during the run-in period which contained a signal 
were eliminated to insure a homogenous comparison of methods.  Insuring that run-in 
data did not include signals facilitated comparison of the change detection methods but 
resulted in an artificial situation.  In reality, practitioners of these methods are not likely 
to take the time to eliminate run-in data containing signals.  Therefore, in order to assess 
changes to interpretation as well as provide a more real-world comparison of 
AUC ROC 
Days 
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methodologies, the data containing signals during run-in were included in a secondary 
analysis.  The analysis below included the 2,892 product-adverse event pairs that had 
been eliminated from the primary analysis, for a total of 22,150 product-adverse event 
pairs available for the analysis.  
 Table 23, Analysis of Data Including the Run-in Signal Data, summarizes the 
sensitivity, specificity, and mean AUC ROC for the change detection methods. 
 
Table 23. Analysis of Data Including the Run-in Signal Data 
Methodology Sensitivity 
Mean  
(SD) 
Specificity 
Mean  
(SD) 
AUC 
ROC 
Mean  
(95% CI) 
Chi-Square 0.64 
(0.41) 
0.56 
(0.37) 
0.77 
(0.70-0.83) 
Modified Chi-square (Evan’s Criteria) 0.28 
(0.33) 
0.93 
(0.11) 
0.63 
(0.59-0.68) 
Control Charting 0.53 
(0.42) 
0.71 
(0.31) 
0.72 
(0.66-0.78) 
Modified Control Charting (Western Electric 
Rules) 
0.84 
(0.30) 
0.23 
(0.30) 
0.87 
(0.80-0.94) 
CUSUM 0.74 
(0.38) 
0.47 
(0.36) 
0.83 
(0.77-0.90) 
Bayesian 0.73 
(0.38) 
0.41 
(0.37) 
0.82 
(0.75-0.89) 
RCI 0.76 
(0.36) 
0.31 
(0.35) 
0.83 
(0.75-0.94) 
Change Point Regression 0.61 
(0.42) 
0.69 
(0.31) 
0.78 
(0.71-0.85) 
 
When compared to the results of the primary analysis, these results differed 
slightly.  In terms of the mean AUC ROC, all values in Table 23 are slightly higher (0.02-
0.04 higher) than the mean AUC ROC values for the primary analysis. 
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One-way ANOVA results indicated a statistically significant difference between 
mean AUC ROC among the eight methods, F(7, 240) = 7.53, p<0.001.  To determine the 
source of the significant results, a subsequent Tukey HSD analysis was conducted to 
examine significant pairwise differences. The significant differences (p<0.05) between 
methods are summarized in Table 24 below. 
 
Table 24. Significant Differences between Methods, Analysis Including Run-in Signal 
Data 
Method 
1. Modified Control Charting 
2. RCI, Bayesian, CUSUM, Change 
Point Regression  
3. Chi-Square, Control Charting 
4. Modified Chi-Square 
Note:  Methods in one row have a statistically significantly greater mean AUC ROC than 
methods listed on rows below. Methods listed in the same cell are not significantly 
different from one another 
 
The pattern of results observed is slightly different from the primary analysis.  
Change point regression was not significantly different from RCI, Bayesian, and 
CUSUM methods, and these methods outperformed all other methods, except modified 
control charting.  Modified chi-square performed statistically significantly worse than all 
other methods based upon mean AUC ROC. 
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 The line graph of AUC ROC by day presents the results indicated by the ANOVA 
analyses.  The line graph shows the consistency of RCI, Bayesian, CUSUM, and change 
point regression.  The accumulated data are summarized in Figure 19 below. 
  
 
Figure 19. AUC ROC Comparison of Change Detection Methods by Day, Analysis 
Including Run-in Signal Data 
 
An additional analysis pertaining to the presence of signal in the run-in data was 
conducted to determine if the presence of a signal during the run-in is predictive of a 
signal during the analysis period.  A 2x2, signal present during run-in, signal present 
during analysis, table was constructed and an odds ratio and corresponding 95% 
AUC ROC 
Days 
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confidence interval was calculated. Table 25 below summarizes the counts in the 2x2 
analysis. 
 
Table 25.  2-by-2 Summary Table for Counts of Signal Product-Adverse Event Pairs for 
Run-In and Analysis Period 
 Signal During 
Analysis 
 
No Signal During 
Analysis 
Row Totals 
Signal During Run-in 522 (18%) 2370 (82%) 2,892 (100%) 
No Signal During 
Run-in 
2952 (15%) 16306 (85%) 19,258 (100%) 
 
Of the total 22,150 product-adverse event pairs, 19,258 had no signal during run-
in and 2892 had a signal identified during the run-in period.  Results of the 2x2 analysis 
indicated that a signal during the run-in period was associated with increased odds of 
having a signal identified during the analysis period (OR=1.22, 95% CI=1.10-1.35). 
Results Summary 
The results generated in the present study provide the information needed to 
complete Table 26, Summary of Candidate Methodologies by Desirable Characteristics 
in Online Monitoring, summarizing the results of the present study of an online, change 
detection task. 
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Table 26. Summary of Candidate Methodologies by Desirable Characteristics in Online 
Monitoring 
Methodology Simple1 Change2 Baseline
3 
AUC 
ROC4 
Time5 
Chi-Square Yes Yes Some - - 
Modified Chi-square 
(Evan’s Criteria) 
Yes Yes No -- -- 
Control Charting Yes Yes Yes - - 
Modified Control Charting  
(Western Electric Rules) 
Yes Yes Yes ++ ++ 
CUSUM Chart No Yes Yes + + 
Bayesian No Yes Some + + 
RCI Yes Yes Yes + + 
Change Point Regression No Yes Yes - - 
1Methodology is computationally simple 
2Methodology detects change in online monitoring of data 
3Methodology leverages historical baseline data 
4Operating characteristics of method, ranked from lowest “—“ to highest “++” 
5Time to detect a change in the online data collection task, ranked from longest “—“ to  
shortest “++” 
 
In terms of the a prior defined desirable characteristics, it is clear that modified 
control charting is the superior choice, followed closely by RCI, Bayesian, and CUSUM 
charting.  Modified control charting was consistently a top performer based upon AUC 
ROC analysis.  In the primary and secondary analyses, RCI, Bayesian, and CUSUM 
methods were not statistically significantly different from each other and performed 
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nearly as well as modified control charting. The ease of computation of the RCI method 
relative to both the CUSUM and Bayesian methods, which require specialized software 
or more complex programming skills, gives an edge to RCI in terms of the applicability 
of this method across many disciplines.  Modified chi-square was consistently 
outperformed by other methods employed.   
Table 27 summarizes the results of all simulations and primary and secondary 
analyses of the actual data by presenting the minimum and maximum value attained 
across all analyses.  The change detection methods are ordered by descending mean AUC 
ROC values. 
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Table 27.  Sensitivity, Specificity, and Mean AUC ROC Minimum and Maximum across 
All Analyses 
Methodology Sensitivity 
Min-Max 
Specificity 
Min-Max 
AUC 
ROC 
Mean 
Min-Max 
Modified Control Charting (Western Electric 
Rules) 
0.81-0.86 
 
0.22-0.26 
 
0.84-0.89 
 
RCI 0.73-0.79 0.31-0.35 0.80-0.85 
CUSUM 0.63-0.76 0.47-0.59 0.80-0.85 
Bayesian 0.67-0.77 0.41-0.49 0.79-0.85 
Change Point Regression 0.44-0.65 0.69-0.81 0.73-0.82 
Chi-Square 0.54-0.68 0.56-0.66 0.72-0.80 
Control Charting 0.40-0.58 0.71-0.81 0.67-0.76 
Modified Chi-square (Evan’s Criteria) 0.14-0.33 
 
0.93-0.97 
 
0.58-0.69 
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GENERAL DISCUSSION 
 The comparison of these eight methods is, to the best of our knowledge, a first - a 
direct comparison of change detection methods common to engineering, public health, 
social science, and physical science disciplines.  Additionally, the incorporation of the 
time component to assess relative performance of these methods prior to a confirmed 
safety signal is novel, allowing the comparison of methods not only based upon accuracy, 
but also based upon the duration over which the change in a data pattern is detected. 
 The present study endeavored to identify the best methods of detecting change 
through the use of simulated data sets as well as data collected in a large-scale consumer 
complaint database.  The simulated data sets were constructed based upon Poisson 
distributed variables which mimic the distribution of reports in the actual safety database.  
The simulated data were constructed presuming weak, moderate, and strong changes in 
the underlying pattern of data.  In addition to providing a basis for comparison of change 
detection methods when change is more and less extreme than change within the actual 
database, use of simulated data bridges these results to results of previous authors which 
relied on simulated data (Matsushita et al., 2007; Nkeng et al., 2011; Almenoff et al., 
2007).  Finally, the comparability of the simulated data results to the results from analysis 
of actual data supports the contention that these analyses are broadly generalizable to 
safety surveillance and similar, Poisson distributed collections of online data (Hauben, 
2007).  
The results summarized in Table 27 provide support for the a priori stated 
hypotheses.  Modified control charting was consistently more sensitive than control 
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charting across all analyses (Hypothesis H1).  Sensitivity for modified control charting 
ranged from 0.81 to 0.86 and sensitivity for control charting ranged from 0.40-0.58. 
Modified chi-square was consistently more specific than chi-square (Hypothesis H2).  
Specificity for modified chi-square ranged from 0.93-0.97 compared to specificities of 
0.56-0.66 for chi-square.   
Hypothesis H3, Bayesian and CUSUM analyses will perform equivalently based 
upon mean AUC ROC, was confirmed by the present study.  ANOVA and Tukey HSD 
analyses provided evidence supporting the hypothesis that Bayesian method would 
perform equivalently to CUSUM, with mean AUC ROCs ranging from 0.79-0.85 for 
Bayesian method and 0.80-0.85 for CUSUM.  This result confirms results of previous 
researchers that the methodologies perform similarly in signal detection tasks (Chen et 
al., 2008) 
Hypothesis H4 stated that CUSUM would perform equivalently to change point 
regression.  Evidence for this hypothesis was mixed, with ANOVA and Tukey HSD 
results indicating a significant difference between these methods on the primary analysis, 
but not all secondary analyses.  CUSUM mean AUC ROC values ranged from 0.80-0.85 
and change point regression mean AUC ROCs ranged from 0.73-0.82.  Though the AUC 
ROC was significantly lower for change point regression for the primary analysis, the 
mean sensitivity and specificity for change point regression were within the range 
expected based upon previous research (Kihara et al., 2011; Riffenburgh & Cummins, 
2006).  Additional studies will be required to accurately characterize the relative 
performance of CUSUM and change point regression. 
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Additionally, literature regarding change point regression suggests that the 
methodology is sensitive to the magnitude of change to be detected and the amount of 
data points collected before and after a change (Chen & Tien, 2010; Höhle & Paul, 2008).  
Change point regression performs best when the change to be detected is large (a 
doubling of the baseline values).  Changes to be detected in the simulated and actual data 
sets in the present study were small in comparison, and therefore change point regression 
did not perform as hypothesized.  Future analytics should examine a broad range of 
change magnitudes to examine the effects on performance of the change detection 
methods. 
Hypothesis H5 stated that RCI will outperform all healthcare methodologies (i.e., 
Bayesian, chi-square, and modified chi-square), and was the result predicted based upon 
the work of Kemmler et al. (2010). Results of the simulated data analyses generally 
supported this result, as RCI consistently outperformed chi-square and modified chi-
square, though RCI was not statistically different from the Bayesian method. 
Similarly, Hypothesis H6 stated that modified control charting and control 
charting would outperform healthcare change detection methodologies (i.e., Bayesian, 
chi-square, and modified chi-square).  This hypothesis was partially supported.  Modified 
control charting consistently outperformed healthcare measures, however, control 
charting generally performed poorly compared to Bayesian and chi-square methods.  It 
would appear the modifications of Western Electric rules to basic control charting are 
necessary to augment the performance in change detection tasks. 
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Examination of control charting within healthcare research has focused primarily 
on control charting and not the modified versions of control charting (Boggs et al., 1998; 
Corcoran & Speekenbrink, 2007).  The results of previous studies have been supportive 
of the use of control charting in these settings, though data comparing control charting to 
standard methods of healthcare signal detection have not been reported.  Results of the 
present study suggest modified control charting may be more effective than control 
charting in change detection.  However, one needs to consider carefully the costs of false 
positive and false negative errors in these settings, which will be discussed in more detail 
below.  Modified control charting outperforms control charting in terms of mean AUC 
ROC (mean AUC ROC is 0.16 greater for modified control charting) but the specificity 
is, on average, 0.42 greater for control charting than for modified control charting. These 
differences could greatly impact the decision to use one method over another if the 
relative costs of false positive or false negative errors dictate the need for more 
specificity. 
Hypothesis H7 stated that results from analyses of simulated data would mimic 
the results of the actual data utilized for the primary analysis.  As described below in the 
next section, Simulated Data Discussion, this hypothesis was supported for the weak and 
moderate effect size simulated data sets.  For the strong effect size data set, differences 
between methods were not as prevalent as the change to be detected was more 
pronounced. 
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Simulated Data Discussion 
The simulation analyses across the three effect size data sets reveal a few key 
findings and provide support for Hypotheses H1-H3 and H7.  First, modified control 
charting performed well under all three effect sizes and was statistically significantly 
better, in comparisons of mean AUC ROC, than all other methods in weak and moderate 
effect size simulated data sets, supporting Hypothesis H1.  When the effect to be detected 
was strong, modified control charting, RCI, CUSUM, and Bayesian methods performed 
equivalently and were statistically significantly better than the other methods.  This result 
demonstrates that Hypothesis H1 is not supported if the change to be detected is 
sufficiently large.   
Consistent with Hypothesis H2 and as noted by several authors (Evans, Waller, & 
Davis, 2001; Matsushita et al., 2007; Hauben, 2007), modification of the simple chi-
square analyses using Evan’s criteria were instituted to limit the tendency of false alarms, 
which can be overly burdensome in a safety surveillance setting.  Each false alarm must 
be documented fully and discounted as a false alarm, with records retained for the 
marketed lifetime of the product under suspicion.  In fact, some authors in healthcare 
safety surveillance have suggested that any change detection method should have a 
specificity of 0.95 (Matsushita et al., 2007).  Though Evan’s criteria limit false alarms, 
the simulated data analyses suggest that the performance of the test barely exceeded 
chance, as the day-to-day AUC ROC plot indicated.  Results from analyses of the actual 
data confirmed this finding in the simulated data sets.  
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Hypothesis H3 was confirmed by the analysis of all three simulated data sets.  
Bayesian and CUSUM methods performed equivalently in the weak and moderate effect 
size, though they were outperformed by modified control charting.  Bayesian and 
CUSUM analyses also performed equivalently in the strong effect size.  Additionally, 
both methods performed equivalently to modified control charting and RCI, which 
outperformed all other change detection methods for the strong effect size simulated data. 
Generally the results of the simulated analyses supported Hypothesis H7, 
simulated data analyses mimicked results of analyses performed on the actual data. The 
only exception to H7 resulted when the effect to be detected was large.  This result could 
have been anticipated, the change detection task gradually becomes ‘easier’ as the change 
to be detected is more pronounced and the differences between methods subsequently 
diminish (Chen &  Tian, 2010; Kihara et al., 2011). 
Primary Analysis Discussion 
Overall, the results of the primary analysis were consistent with the analysis of the 
simulated data and consistent with the hypothesized results, Hypothesis H7.  Modified 
control charting performed significantly better than other methods.  Though RCI, 
Bayesian, and CUSUM do not perform as well as modified control charting, they do 
perform significantly better than all other methods.  Additionally, the higher specificity 
values for RCI, Bayesian, and CUSUM methods compared to modified control charting 
may make these methods preferable in circumstances where false positives are costly. 
It was hypothesized that change point regression would perform similarly to 
CUSUM, however, CUSUM statistically outperformed change point regression 
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(Hypothesis H4).  It appears that change point regression requires additional data points 
before a signal is declared, and therefore is more specific than CUSUM, consistent with 
results presented by others (Chen &  Tian, 2010; Zeileis, Kleiber, Krämer, & Hornik, 
2003).  The mean specificity is 0.22 greater for change point regression than CUSUM.  
However, the mean AUC ROC is 0.06 lower for change point regression due to the 
relatively large sensitivity of CUSUM.  Subsequent secondary analyses were conducted 
to examine the robustness of these findings. 
Secondary Analysis Discussion 
In order to examine the consistency of the primary analysis under different 
volumes of product-adverse event combinations, the primary analysis data set was 
divided into three segments: most-frequent, mid-frequent, and least-frequent product-
adverse event pairs in the data set based upon the total number of reports.   For each of 
these three segments of the database, the primary analyses were re-run, sensitivity and 
specificity computed, and mean AUC ROC summarized and compared using one-way 
ANOVAs.  Results shifted only minimally across the three subsets, indicating that 
frequency of the events within the database did not alter the conclusions of the primary 
analysis.  This result is counter to the assertion of Evans, Waller, and Davis (2001), that 
the frequency of reporting of product-adverse event pairs could affect accuracy of 
measures.  The results of the present study demonstrated no difference based upon 
frequency of events.  The difference is likely due to the fact that the Evans et al. study 
involved 15 pharmaceutical products, whereas the present study contains data from 1,777 
total products.  It is likely the heterogeneity of data in the present study is responsible for 
  133 
   
findings different from those previously documented in the literature.  Evans et al. may 
have detected chance differences that resulted from analysis conducted on subsets of their 
limited data. 
In order to examine the consistency of the primary analysis when the run-in data 
with safety signals is included in the analysis, the primary analysis was rerun including 
these data.  Results differed from that of the primary analysis, but not dramatically.  As 
with the product-adverse event volume analysis, there were no shifts in the serial order of 
the change detection methods, though slight differences emerged in the ANOVA results 
and line graphs.  Overall, it is fair to conclude that inclusion of the run-in data that 
included a signal did not have an impact on the relative performance of the change 
detection methods.   
Interestingly, the exploratory analysis of the relationship between the presence of 
a signal during the run-in period and a signal during the analysis period demonstrated a 
significant positive relationship.  This result may be useful to resource-constrained 
surveillance departments, where assigning physicians to all products and all events is 
impossible (Bate & Reynolds, 2010; Hauben, 2007; Reynolds & Woodall; 2003).  
Focusing resources on products and events with a history of signaling may be more 
efficient. 
In order to examine the consistency of the primary analysis when the qualitative 
and quantitative signals were both included in the analysis, the primary analysis was 
rerun including both types of signals.  Results were consistent with that of the primary 
analysis: modified control charting was superior to other methods, and RCI, Bayesian , 
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CUSUM, and change point regression were close behind.  This result may be due in part 
to two factors: the small number of qualitative signals and the process for identifying 
qualitative signals.   
First, the number of qualitative signals relative to the total number of signals is 
small, only 15% of the total number of signals.  The pattern of data present within 
qualitative signals would need to be drastically different from quantitative signals to 
result in measurable differences in the mean AUC ROC given this small percentage. 
Second, the process for identification of quality signals is not entirely independent 
of considerations of quantitative change.  Safety physicians familiar with the process 
admit that quality signals are often accompanied by slight quantitative increases in the 
frequency of reports of a particular product-adverse event pair, though the reporting 
increase is not sufficiently dramatic to trigger a quantitative signal.  Anecdotally, at least, 
the differentiation between quantitative and qualitative signals is not as clearly delineated 
as this dichotomous classification system might suggest.  Given the results of the data 
and analysis, inclusion of the qualitative signals does not change the overall conclusions 
reached by the analysis of change detection methods. 
The primary analysis was rerun with Day 0 assigned at random in the noise 
distribution.  Results differed from that of the primary analysis, but not dramatically so, 
and were consistent with other subset analyses, such as the secondary analysis including 
run-in data containing a safety signal.  There are no dramatic shifts in the serial order of 
the change detection methods, though slight differences emerge in the ANOVA results 
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and line graph.  The conclusion of this analysis is that selecting an arbitrary data cut off 
(in the case of the present study, June 1st, 2013) did not affect the interpretation of results. 
Limitations of the Present Study 
A component of the current analysis that limits the generalizability of the findings 
is the definition of the gold standard.  For change detection tasks in healthcare and many 
other fields, use of a judgment-based gold standard of truth is necessary, but not ideal 
(Spiegelman, Schneeweiss, & McDermott,1997).  Though the method for determining the 
gold standard for a safety signal is rigorous, see Appendix B for a schematic of the 
process, and routinely applied within the healthcare industry (Matsushita, 2007), it is still 
a judgment.  To combat this criticism, primary and secondary analyses were compared to 
analyses based upon simulated data to verify consistency of results.  Results were found 
to be consistent; nonetheless, variability in the judgment process could alter conclusions 
reached in the present study.  Analyses should be conducted on a large-scale database 
with an objective gold standard to verify the results of the present study. 
The selection of a 31-day analysis period was chosen as a timeframe that would 
allow methods to be compared and was demonstrated to be sufficient to reveal 
differences between methods.  However, in certain fields, healthcare included, it is very 
challenging to update data on a frequent (daily) basis due to the labor involved in 
entering, reviewing, and verifying data before it is deemed ‘clean’ for analysis.  In 
healthcare, it is routine to use modified chi-square analyses to analyze data on a quarter-
by-quarter basis (Boggs et al., 1998; Corcoran & Speekenbrink, 2007; Li & Kulldorff, 
2010; Stoumbos, Reynolds, & Woodall, 2003).  Future studies should examine a larger 
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timeframe, 60 days or 90 days, to determine the effects on the interpretation of results.  It 
is possible that the longer timeframe would reveal the mean AUC ROC analyses to be 
increasingly similar with time.  This information would be particularly interesting to 
fields of study where rapid collection and analysis of data is not possible. 
The primary analysis for comparison of the change detection methods were 
ANOVA models applied to AUC ROC values.  AUC ROC values were computed by 
altering the cutoff values higher and lower than the cutoff typically used for the methods.  
Due to the lack of information regarding alternative cutoffs, it is possible that cutoffs 
were selected that did not adequately estimate the true ROC curve.  Specifically, there is 
no way to insure the cutoffs for one method are equivalent cutoffs for use in another 
method.  Therefore, some ROC curves may have been more broadly distributed and 
characterize the curve more accurately than cutoffs for another method.  Failure to 
accurately capture the entire curve could underestimate the AUC ROC values and impact 
results of the present study.  Future research should consider additional cutoff values and 
a broad range of cutoff values to determine if the results hold. 
Additional analyses of the time-accuracy components of the data may yield 
additional insights.  For example, the present study did not include a multivariate analysis 
of the mean AUC ROC data which included the time variable.  Investigation of the 
relationship between the time component and the AUC ROC values may yield additional 
information regarding how the performance of these measures varies over time.  This 
information could further aid in the selection of the optimal change detection method for 
a specific task.  
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Conclusions and Future Study of Change Detection Methods 
The present study demonstrates the relative performance of change detection 
methods in online change detection tasks.  Table 26 summarizes the operating 
characteristics of the change detection methods across all analyses, across simulated and 
actual data sets.  The information contained in that table may assist future researchers in 
the selection of change detection methods appropriate for a given field of study.  In fact, 
the results of the present study have begun to shape the pharmacovigilance analysis and 
reporting environment within the consumer company that provided the data for analysis.  
Programming that will run modified control charting on a daily basis against a subset of 
100 products is completed and currently going through the software development and 
validation process required within regulated safety reporting environments.  Once 
completed, the modified control charting algorithm will run in parallel with status quo 
analyses, modified chi-square and Bayesian analyses.  Results of this pilot study will be 
examined to compare both signal detection performance and the logistical challenge that 
may result from changing to a new analysis method – a method that results in more 
signals and also more false alarms.  Results of this pilot effort are expected late 2015.  At 
a minimum, it is expected that the results of this study will allow for an informed triage 
procedure – reducing the effort of individuals by focusing their attention on the product-
adverse event pairs that are identified by change detection methods. 
The approach of this company illustrates a key consideration for future change 
detection method application.  Table 27 provides useful information regarding the 
sensitivity, specificity, and AUC ROC for each method.  This information needs to be 
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combined with considerations regarding costs of errors within a discipline.  For example, 
as noted by Matsushita et al, the cost of false alarms may be a resource drain that 
prohibits regular tracking of potential signals.  Alternatively, the cost of missing a true 
signal could result in massive product recalls threatening the ability of a company to 
continue to do business.  After costs of errors have been weighed, the information in 
Table 27 may be used to select the most appropriate methodology.  The best method may 
not be the method with the highest AUC ROC, but maybe the highest sensitivity, 
specificity, or some combination of methods based upon trade-offs of sensitivity and 
specificity. 
The work of Draper and his colleagues provide a framework for leveraging the 
value of the results of this study.  They contend statistics may be generated for three 
reasons: description, inference, and decision making (Fouskakis & Draper, 2008; 
Fouskakis, Ntzoufras, & Draper, 2009).  In cases where statistics are used for decision 
making, as in the present study to make a decision about the presence of a safety signal, 
probability of being correct can be modeled along with utility functions related to the 
costs of making incorrect decisions.  The present study provides the information needed 
to estimate the probability of being correct. Future research could marry elicited utility 
functions of safety physicians in safety signal detection to generate a complete decision 
tree for choosing the optimal change detection methodology. 
 The value of examining analysis methods from a broad range of fields was 
demonstrated by the present study.  The top performers in a comparison based upon a 
safety surveillance task originated not in healthcare, but in the fields of engineering and 
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psychology.  Further study is needed to confirm these results using different databases 
under different conditions to determine the operating characteristics of the methodologies 
best aligned to the goals of a specific change detection task. 
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APPENDIX A: SAS CODE FOR CHANGE POINT ANALYSIS 
proc mcmc data=<Input Data>; 
   parms alpha cp beta1 beta2; 
   parms s2; 
    
/* Priors selected so as to be uninformative */ 
   prior cp~unif(<lower bnd Day -30>, <upper bnd Day 0>); 
   prior alpha beta: ~ normal(0, v = 1e6); 
   prior s2  ~ uniform(0, 1000); 
    
   if(x < cp) then 
      mu = alpha + beta1 * (x - cp); 
   else 
      mu = alpha + beta2 * (x - cp); 
   model y ~ normal(mu, var=s2); 
run; 
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APPENDIX B: DATA FLOW 
 
  
Product on Market 
Unexpected 
product event 
Complaint 
reported 
Potential Adverse 
event present 
Physician review 
Event escalated to 
management - 
SIGNAL 
Action taken 
Not action at this 
time 
Determined no 
safety risk 
NO SIGNAL 
No Adverse Event 
Complaint not 
reported 
Product performs 
as expected 
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APPENDIX C: SAMPLE FROM THE ADVERSE EVENT DATABASE 
  
Removed to protect confidentiality of products and reports 
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APPENDIX D: DATA AVAILABLE FOR ANALYSIS 
Num Variable Type Len Label 
1 
Age At Onset of Adverse 
Event CR Char 2 
Age At Onset of Adverse 
Event CRS 
2 Alert date Char 10 Alert date 
3 Aware Date Copy Char 10 Aware Date Copy 
4 Aware Month Num 8 Aware Month 
5 Aware QTR Char 2 Aware QTR 
6 Aware Year Num 8 Aware Year 
7 cat_desc Char 68 cat_desc 
8 cat_lvl2_desc Char 19 cat_lvl2_desc 
9 cat_lvl3_desc Char 39 cat_lvl3_desc 
10 Causality RSS Char 16 Causality RSS 
11 Causality WHO Char 15 Causality WHO 
12 Clinical Impact Char 19 Clinical Impact 
13 Clinical Severity Char 8 Clinical Severity 
14 Close Date Char 10 Close Date 
15 Close Date Copy Char 10 Close Date Copy 
16 Close MTH Num 8 Close MTH 
17 Close QTR Char 2 Close QTR 
18 Close Year Num 8 Close Year 
19 cntct_cntr_no Char 11 cntct_cntr_no 
20 Confirmed Safety signal Char 1 
Confirmed Safety Signal Y 
or N 
21 CRS latest update date Char 10 CRS latest update date 
22 Duration of Event Char 12 Duration of Event 
23 event_desc Char 255 event_desc 
24 event_exp_rpt Char 3 event_exp_rpt 
25 ext_notes Char 255 ext_notes 
26 fmly_lvl1_desc Char 17 fmly_lvl1_desc 
27 fmly_lvl2_desc Char 27 fmly_lvl2_desc 
28 fmly_lvl3_desc Char 37 fmly_lvl3_desc 
29 Gender Char 6 Gender 
30 hist_tracking_no Char 10 hist_tracking_no 
31 hosp Char 3 hosp 
32 intervention_req Char 3 intervention_req 
33 j_j_aware_dt Num 8 Date of event 
34 Legacy v01 Char 1 Legacy v01 
35 lot_no Char 20 lot_no 
36 LSR Char 16 LSR 
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37 MDCS Char 1 MDCS 
38 MedDRA PT 1 Syndrome Char 44 MedDRA PT 1 Syndrome 
39 Merged Char 3 Merged 
40 MTNS Char 4 MTNS 
41 Portfolio GEC Placeholder Char 1 Portfolio GEC Placeholder 
42 Relative Risk Num 8 Relative Risk 
43 RSS MedDRA PT 1 Char 42 RSS MedDRA PT 1 
44 RSS MedDRA PT 2 Char 8 RSS MedDRA PT 2 
45 RSS MedDRA PT 3 Char 1 RSS MedDRA PT 3 
46 RSS MedDRA PT 4 Char 1 RSS MedDRA PT 4 
47 RSS MedDRA PT 5 Char 1 RSS MedDRA PT 5 
48 RSS Narrative Char 255 RSS Narrative 
49 SDE Char 14 SDE 
50 SMQ Char 1 SMQ 
51 SMQ Anaphylactic Char 21 SMQ Anaphylactic 
52 SMQ Infection Char 4 SMQ Infection 
53 SMQ Oral injury Char 11 SMQ Oral injury 
54 SMQ Sensates Char 8 SMQ Sensates 
55 SMQ Skin injury Char 11 SMQ Skin injury 
56 SMQ Skin irritation Char 15 SMQ Skin irritation 
57 SOC Char 1 SOC 
58 SOC Name Char 68 SOC Name 
59 SRI Char 1 SRI 
60 StudyDay Num 8 Days Prior to Safety Signal 
61 Unique ID Num 8 Unique ID 
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APPENDIX E: 3D ROC ANALYSIS AND SAMPLE 3D AUC ROC FIGURES 
The present study utilized a database that contains details of the products, events, 
the determination of a safety signal as well as the date a safety signal was declared.  
Therefore, the data were analyzed to compute sensitivity, specificity, at specific time 
points prior to the confirmation of a safety signal.  Having a consistently applied 
determination of safety signal allowed the computation of sensitivity and specificity of 
each analysis method at various time points and various threshold cutoff values for each 
analysis method.  The resulting sensitivities, specificities, and time prior to gold standard 
confirmed safety signal were plotted on a 3-D surface such as that below in Sample 
Image 1  (Flach, 2003). 
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Sample Image 1. Sensitivity-Specificity-Time 3D ROC for 4 Hypothetical 
Analysis Methods 
 
The 3D representation includes lines connecting data points computed for various 
sensitivity/specificity cutoffs for 4 different analysis methodologies.  Including the time 
component makes clear that certain cutoffs provide greater sensitivity without sacrificing 
specificity over time.  Other cutoffs reveal no increase in sensitivity or specificity over 
time.   
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For comparison, consider the above 3D plot rotated so the time axis is nearly 
invisible (Sample Image 2).  This displays the 4 methodologies, but without the time 
component.  Examining the figure reveals, as would be expected, that it is impossible to 
see a relationship between the accuracy and time measures.  This graphic representation 
illustrates the limitation of typical 2-D ROC analyses.  Without simultaneous 
consideration of the time component, there is little difference among the methods. 
Sample Image 2. Sensitivity-Specificity-Time 3D ROC, Time Minimized
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 The 3D representation provides graphic evidence of the performance of a method 
over a period of time in the database.  The data may also be tabulated and the volume 
encompassed by the surface created by the curves above calculated.  A test which has 
high specificity and sensitivity and detects signals early in the time trend will have a 3D 
ROC volume near 1.0.  These computed areas may be used to compare candidate 
methodologies. 
Other authors have extended the use of ROC curves to multiple dimensions.  
Flach (2003) noted that considering a 3rd dimension in conjunction with sensitivity and 
specificity in machine learning can illuminate relationships not obvious by considering 
the pairwise relationships in isolation.  In a health care example, Zheng and Heagerty 
(2004) describe a semi-parametric method for estimation of time dependent ROC curves. 
Their method can be used to create a series of time dependent ROC curves, but falls short 
of including time as a third dimension and computing volumes under the 3-D surfaces.  
This study represents the first use of 3-D surfaces and volume computation as a means 
for comparing the relative performance of a series of analysis methods.  Additionally, as 
noted previously, the methods detailed above in Table 6 are often employed as common 
practice, or habit, without adequate consideration to the performance. This paper 
addresses this deficiency, finally providing evidence of the performance of these 
measures in a field where longitudinal data capture is common practice – safety 
surveillance.  This methodology may be applied anywhere that time, or other third 
dimension of interest, is thought to be related to the performance of a test.   
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After completion of analyses, it became clear the 3D ROC figures were not 
providing the clarity desired to differentiate between methods.  As noted in-text, the line 
graphs replaced the 3D ROC surfaces.  See figures below for an example of the lack of 
fidelity. 
Sample Image 3: Bayesian Analysis of Simulated Data, Weak Effect 
 
Sample Image 4: Bayesian analysis of Simulated Data, Strong Effect 
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APPENDIX F: HISTOGRAM OF MONTHLY ADVERSE EVENT COUNTS 
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